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Foreword
The National Institute for Occupational Safety and Health (NIOSH) has estimated 
that workplace skin diseases account for 15%–20% of all reported occupational 
diseases in the United States, with estimated total annual costs (including lost 
workdays and lost productivity) up to $1 billion. Skin exposures to chemicals can 
cause a wide array of injuries and illness including contact dermatitis, immune-
mediated responses, and irreversible damage to the skin. Despite the relatively high 
incidence of contact dermatitis and other workplace skin diseases, the impact and 
risk of skin contact with chemicals and other hazardous agents are not well known, 
hampering the recognition and prevention of these disorders. Additionally, skin 
contact represents a significant route of exposure for chemicals that have the po-
tential to be percutaneously absorbed and subsequently cause systemic effects in-
cluding, but not limited to, acute toxicity, cancers, neurotoxicity, and effects on the 
reproductive system. 
NIOSH has long recognized the hazards of skin contact with chemicals in the work-
place and the importance of quality research and policies to prevent such exposures. 
In 1999, NIOSH launched an Interdisciplinary Cross-Sectional Research Program 
as part of the National Occupational Research Agenda (NORA). This Dermal Expo-
sure Research Program (DERP) was established to promote the identification and 
control of skin exposures to hazardous agents and conditions in the workplace. The 
focus of DERP was to expand the current knowledge base through laboratory and 
field research and to apply scientific decision-making processes for policy develop-
ment. NIOSH has entered the second decade of NORA and, through its Immu-
nological and Dermal Cross-Sector Program, continues to investigate methods for 
protecting workers from hazardous skin exposures and for reducing the prevalence 
of occupational skin diseases.
NIOSH skin notations are hazard warnings used worldwide to alert workers and 
employers to the health risks of skin exposures to chemicals in the workplace. This 
Current Intelligence Bulletin (CIB) provides the rationale for assigning new NIOSH 
skin notations. The new system reflects the current state of scientific knowledge and 
involves critical evaluation of scientific data so that scientists can assign multiple 
skin notations that distinguish between the systemic, direct, and sensitizing effects 
of skin exposures to chemicals. This new strategy is a form of hazard identifica-
tion that advances our understanding of the hazards posed by skin exposures to 
chemicals. Such improved understanding will enable us to implement better risk 
 management practices and controls for the prevention of workplace skin diseases 
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and other occupational diseases where skin exposure may contribute to disease de-
velopment.
Christine M. Branche, Ph.D. /s
Acting Director, National Institute for 
Occupational Safety and Health 
Centers for Disease Control  
   and Prevention
vExecutive Summary
For more than 20 years, the occupational safety and health community has relied 
on skin notations from the National Institute for Occupational Safety and Health 
(NIOSH) to warn workers about the health hazards of skin exposures to chemicals. 
These notations have proved to be useful risk management tools for occupational 
health professionals concerned about protecting workers from injuries and illnesses 
caused by skin contact with chemicals. However, according to the definition, a NIOSH 
skin notation may be assigned to a chemical only if that substance has been scientifi-
cally determined to be dermally absorbed. The current, widespread practice of using 
a skin notation to indicate that a substance poses other health effects, such as skin ir-
ritation, following any kind of skin exposure is inaccurate and misleading. 
Difficulties with Assigning Current NIOSH Skin Notations 
NIOSH adopted the skin notations for 142 chemicals as part of its 1988 testimony to 
the Occupational Safety and Health Administration’s (OSHA) proposed rule on Air 
Contaminants (Permissible Exposure Limit update). The skin notations for these 
chemicals are listed in the NIOSH Pocket Guide to Chemical Hazards by the sym-
bol [skin]. Despite the usefulness of the skin notations as a risk management tool, 
NIOSH has identified several conceptual difficulties with the ways in which skin 
notations have been assigned:
1. The current NIOSH system relies on a single skin notation that is intended to 
warn against the potential for a chemical to be dermally absorbed and contrib-
ute substantially to systemic toxicity. This skin notation is not intended to be 
applied to chemicals that would cause direct effects to the skin or to chemicals 
that have the potential to act as a sensitizer. 
2. The NIOSH skin notation has not been assigned on the basis of a standard-
ized methodology. As a result, chemicals have been improperly assigned a skin 
notation as a warning for nonsystemic effects, such as skin irritation and cor-
rosion, thereby causing confusion about what types of risk-management prac-
tices should be undertaken to prevent skin exposure. 
3. The NIOSH skin notation does not reflect the contemporary state of scientific 
knowledge or recommendations made in NIOSH criteria documents since the 
1988 Permissible Exposure Limit update.
New Strategy for Assigning NIOSH Skin Notations
This document, Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New 
NIOSH Skin Notations, provides a new strategy for assigning skin notations. The 
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strategic framework outlined within this document is a form of hazard identifica-
tion that has been designed to do the following:
 • Ensure that the assigned skin notations reflect the contemporary state of sci-
entific knowledge
 • Provide transparency behind the assignment process
 • Communicate the hazards of chemical exposures of the skin
 • Meet the needs of health professionals, employers, and other interested par-
ties in protecting workers from chemical contact with the skin
This strategy involves the assignment of multiple skin notations for distinguishing 
systemic (SYS), direct (DIR), and sensitizing (SEN) effects caused by exposure of 
skin (SK) to chemicals. Chemicals that are highly or extremely toxic and may be 
potentially lethal or life-threatening following exposures of the skin are designated 
with the systemic subnotation (FATAL). Potential irritants and corrosive chemicals 
are indicated by the direct effects subnotations (IRR) and (COR), respectively. Thus 
with the new strategy, chemicals labeled as SK: SYS are recognized to contribute to 
systemic toxicity through dermal absorption. Chemicals assigned the notation SK: 
SYS (FATAL) have been identified as highly or extremely toxic and have the poten-
tial to be lethal or life-threatening following acute contact with the skin. Substances 
identified to cause direct effects (i.e., damage or destruction) to the skin limited to 
or near the point of contact are labeled SK: DIR, and those resulting in skin irrita-
tion and corrosion at the point of contact are labeled as SK: DIR (IRR) and SK: DIR 
(COR), respectively. The SK: SEN notation is used for substances identified as caus-
ing or contributing to allergic contact dermatitis (ACD) or other immune-mediated 
responses, such as airway hyper reactivity (asthma). Candidate chemicals may be 
assigned more than one skin notation when they are identified to cause multiple 
effects resulting from skin exposure. For example, if a chemical is identified as cor-
rosive and also contributes to systemic toxicity, it will be labeled as SK: SYS-DIR 
(COR). When scientific data for a chemical indicate that skin exposure does not 
produce systemic, direct, or sensitizing effects, the compound will be assigned the 
notation (SK). The ID(SK) notation is assigned to indicate that insufficient data on 
the health hazards associated with skin exposure to a substance exist at the time of 
the review to determine whether the chemical has the potential to act as a systemic, 
direct, or sensitizing agent. The ND notation indicates that a chemical has not been 
evaluated by the strategy outlined in this CIB and that the health hazards associated 
with skin exposure are unknown. 
The new skin notation strategy is a form of health hazard identification that stan-
dardizes the method for deriving skin notations. Assignment of the new NIOSH 
skin notations to chemicals relies on a critical assessment of the following:
 • A substance’s physicochemical properties
 • Reports of human exposures and health effects
 • Empirical data from in vivo and in vitro laboratory testing
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 • Considerations provided by computational techniques, such as predictive 
algorithms (e.g., QSAR) and mathematical models (e.g., skin permeation)
A weight-of-evidence approach is applied in evaluating the quality and constituency 
of the scientific data when conflicting findings are reported. Figure 1 illustrates an 
overview of the process used to assign skin notations. 
The new strategy for assigning the NIOSH skin notations was designed to preserve 
the conventional wisdom about them and also to address the issues associated with 
their historic misuse—including their assignment to nonsystemic effects. This sys-
tem provides a framework for assigning multiple skin notations that incorporates 
the current scientific database on workplace chemicals and dermal toxicity. The new 
system warns users about the direct, systemic, and sensitizing effects of exposures 
of the skin to chemicals. The labeling of a chemical with a hazard-specific skin nota-
tion (and in some cases multiple notations) will greatly enhance the quality of haz-
ard communication and the associated risk management process. The new strategy 
outlined in this CIB also corresponds with the classification strategy adopted in the 
Globally Harmonized System of Classification and Labeling of Chemicals (GHS) de-
veloped by the United Nations (see Appendix G.2). This CIB will be updated as new 
scientific data becomes available.
Historically, skin notations have been published in the NIOSH Pocket Guide to 
Chemical Hazards. This practice will continue with the NIOSH skin notation as-
signments for each evaluated chemical being integrated as they become available. A 
support document called a Skin Notation Profile (see Appendix F) will be developed 
for each evaluated chemical. The Skin Notation Profile for a chemical will provide 
information supplemental to the skin notation, including a summary of all relevant 
data used to aid in determining the hazards associated with skin exposures.
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Figure 1. Decision tree for assigning new NIOSH skin notations
Select candidate chemical substance (Appendix D)
Apply literature search strategy (Appendix E.1)
Identify and select critical data, studies, and information (Chapter 2.0)
Review and evaluate critical data, studies and information (Chapter 2.0, Appendix E.2)
Are there sufficient data to assign skin notations?
Are data supportive to assign skin 
notations? (Chapter 2, Appendix A, B, C)?
Assignment of 
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Abbreviations
ACD allergic contact dermatitis
ACGIH American Conference of Governmental Industrial Hygienists
CIB Current Intelligence Bulletin
cm centimeter(s)
cm2 square centimeter(s)
cm/hr centimeter(s) per hour 
(COR) subnotation of SK: DIR indicating the potential for a chemical to be 
corrosive following exposure of the skin
CFR Code of Federal Regulations
DEREK™ Deductive Estimation of Risk from Existing Knowledge
DIR skin notation indicating the potential for direct effects to the skin fol-
lowing contact with a chemical
EC European Commission
ECETOC European Centre for Ecotoxicology and Toxicology of Chemicals
ECVAM European Centre for the Validation of Alternative Methods
(FATAL) subnotation of SK: SYS indicating chemicals are highly or extremely 
toxic and may be potentially lethal or life threatening following expo-
sure of the skin
g gram(s)
g/kg gram(s) per kilograms of animal body weight
g/kg-day gram(s) per kilograms of animal body weight per day
GHS Globally Harmonized System of Classification and Labeling of 
Chemicals
hr hour(s)
IARC International Agency for Research on Cancer
xiii
ICCVAM Interagency Coordinating Committee on the Validation of Alterna-
tive Methods
ICSC International Chemical Safety Cards
ID(SK) skin notation indicating that a chemical has been evaluated, but in-
sufficient data exist to accurately assess the hazards of skin exposure
(IRR) subnotation of SK: DIR indicating the potential for a chemical to be 
a skin irritant following exposure to the skin
Kaq  coefficient in the watery epidermal layer
kg kilogram(s)
KOW  octanol-water partition coefficient
Kp skin permeation coefficient
Kpol coefficient in the protein fraction of stratum corneum
Kpsc permeation coefficient in the lipid fraction of stratum corneum
LD50  lethal dose 50% by skin, oral, and intradermal routes
LLNA local lymph node assay
LOAEL lowest-observed-adverse-effect level
LOEL lowest-observed-effect level
m meter(s)
m2 squared meter(s)
m3 cubic meter(s)
MEST mouse ear swelling test
μg/cm2 microgram of a substance/ squared centimeter
mg milligram(s)
mg/cm3 milligram(s) of a dissolved substance/cubic centimeter meter of solute
mg/cm3/hr milligram(s) of a dissolved substance/cubic centimeter meter of sol-
ute/hour
mg/kg milligram(s) of a substance/kilograms animal body weight 
mg/kg-day milligram(s) of a substance/kilograms animal body weight as a daily 
dose
xiv
mg/m3 milligram(s) of a substance per cubic meter of air 
MW molecular weight
ND notation used to indicate that a chemical has not been evaluated by 
the strategy outlined in this CIB, and that the health risks associated 
with skin exposure are unknown. 
NIOSH National Institute for Occupational Safety and Health
NOAEL no-observed-adverse-effect level
NOEL no-observed-effect level
NTP National Toxicology Program 
OECD Organization for Economic Cooperation and Development 
OEL occupational exposure limit
OSHA Occupational Safety and Health Administration
QSAR quantitative structure-activity relationship
QSPR quantitative structure-permeability relationship
RF  retention factor
RTECS Registry of Toxic Effects of Chemical Substances
R-phrases risk phrases
SAR structure-activity relationship
SI ratio ratio of the skin dose to the inhalation dose
SEN skin notation indicating the potential for immune-mediated reac-
tions following exposure of the skin
SK skin notation
SK skin notation indicating that the reviewed data did not identify a 
health risk associated with skin exposure
SYS skin notation indicating the potential for systemic toxicity following 
exposure of the skin
SW water solubility
TER transcutaneous electrical resistance assay
U.S. EPA U.S. Environmental Protection Agency 
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Glossary
Absorption—The transport of a chemical from the outer surface of the skin into both 
the skin and systemic circulation (including penetration, permeation, and resorption).
Acute—Contact with a chemical that occurs once or for only a short period of time.
Cancer—Any one of a group of diseases that occurs when cells in the body become 
abnormal and grow or multiply out of control.
Contaminant—A chemical that (1) is unintentionally present within a neat substance 
or mixture in concentrations less than 1.0% or (2) is recognized as a potential carcino-
gen present within a neat substance or mixture in concentrations less than 0.1%.
Cutaneous (percutaneous)—Referring to the skin. 
Dermal—Referring to the skin. 
Dermal contact—Contact with (touching) the skin.
Dermatosis—A disease or disorder of the skin. 
Direct effects—Localized non-immune mediated adverse health effects to the skin oc-
curring at or near the point of contact, including corrosion, primary irritation, changes 
in skin pigmentation, and reduction/disruption of the skin barrier integrity, following 
skin exposure to chemicals. 
Immune-mediated responses—Responses mediated by the immune systems in-
cluding allergic responses. 
Isomers—Molecules that exhibit unique physical structures, but consist of the same el-
emental composition and weight that may result in significant difference in toxic potency.
Photocarcinogenesis—The elicitation or increase of a carcinogenic response after 
skin exposure to a photo reactive chemical and subsequent exposure to sunlight. 
Phototoxicity—The elicitation or increase of a toxic response after skin exposure to 
a photo reactive chemical and subsequent exposure to sunlight.
Sensitization—A specific immune-mediated response that develops following ex-
posure to a chemical, which, upon re-exposure, can lead to allergic contact derma-
titis (ACD) or other immune-mediated diseases such as asthma, depending on the 
site and route of re-exposure. 
Substance—A chemical. 
Systemic effects—Systemic toxicity associated with skin absorption of chemicals 
after exposure of the skin.
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11 Introduction
The skin* is the largest organ of the human body 
and accounts for more than 10% of the body’s 
mass. It enables the body to readily interact with 
the environment and also serves as a general 
defense system. It also represents a potentially 
significant exposure pathway for many chemi-
cals because of the large surface area [1.5–2.0 
squared meters (m2)] available for contact to 
any one of the innumerable potentially toxic 
substances in the workplace. The health and 
economic impacts of such exposures are not ful-
ly understood because of the inherent difficul-
ties in differentiating between the contribution 
of dermal absorption of a chemical and other 
routes of entry (i.e., inhalation and ingestion) 
to total body burden and subsequent onset of a 
specific disease or disorder. Additionally, less at-
tention is often given to characterizing occupa-
tional and environmental exposures of the skin 
to chemicals than is given to other exposure 
pathways. These limitations potentially leave ex-
posed workers susceptible to a wide spectrum of 
adverse health outcomes including dermatoses, 
systemic toxicity, and, in extreme cases, death. 
The National Institute for Occupational Safety 
and Health (NIOSH) currently uses [skin] as 
*The terms dermal, cutaneous, and percutaneous refer to 
the skin. These terms are used interchangeably within 
this document. 
the skin notation on 142 chemicals listed in the 
NIOSH Pocket Guide to Chemical Hazards to 
alert workers and employers to the potential 
of skin absorption [NIOSH 2005]. This skin 
notation was adopted by NIOSH in its testi-
mony on the Occupational Safety and Health 
Administration (OSHA) Proposed Rule on Air 
Contaminants (Permissible Exposure Limit 
update) on August 1, 1988 [NIOSH 1988]. De-
spite the usefulness of the notation [skin] as a 
risk management tool, it provides little guid-
ance about a chemical other than warning of 
its possible absorption through the skin.
The assignment of skin notations has several 
inconsistencies and limitations:
1. The skin notation is based in theory on 
the potential contribution a chemical 
makes to systemic toxicity when it is ab-
sorbed by the skin [54 CFR 2718 (1989)]. 
However, the notation has not been con-
sistently assigned according to this prin-
ciple. Many skin notations are based only 
on the potential or reported transdermal 
penetration of chemicals—with no con-
sideration of the causality between der-
mal absorption and overall toxicity. 
2. A single skin notation assigned to a 
chemical was often used to warn of se-
rious dermal effects other than systemic 
toxicity—effects such as irritation, corro-
sion, and sensitization. According to its 
A Strategy for Assigning New NIOSH Skin 
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current definition, a skin notation is as-
signed to a chemical only when the sub-
stance has been scientifically established 
to be dermally absorbed and to poten-
tially contribute to systemic toxicity. Use 
of the notation [skin] as an indicator for 
other health effects from skin exposure is 
inappropriate and misleading. 
3. The skin notation does not reflect the 
contemporary state of scientific knowl-
edge or include recommendations made 
in NIOSH criteria document since the 
1988 Permissible Exposure Limit update 
project. For example, the criteria docu-
ment for ethylene glycol monomethyl 
ether, ethylene glycol monoethyl ether, 
and their acetates recommends that skin 
exposures to these chemicals be avoided 
because of their ability to be readily ab-
sorbed by the skin [NIOSH 1991]. How-
ever, none of these chemicals has been as-
signed a skin notation.
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2 Assigning Skin Notations 
The Current Intelligence Bulletin (CIB) 61: A 
Strategy for Assigning New NIOSH Skin No-
tations provides an updated and formalized 
strategy for the assignment of skin notations 
capable of distinguishing among systemic, 
direct, and sensitizing effects caused by expo-
sures of the skin to chemicals. The strategic 
framework outlined within this document is a 
form of hazard identification that has been de-
signed to accomplish the following: 
1. Ensure that the assigned skin notations 
reflect the contemporary state of scien-
tific knowledge
2. Provide transparency to the assignment 
process
3. Communicate the hazards of chemical 
exposures of the skin
4. Meet the needs of health professionals, 
employers, and other interested parties in 
protecting workers from chemical con-
tact with the skin 
The system preserves the conventional wis-
dom for assigning skin notations to chemicals 
that pose a hazard from skin contact. In addi-
tion, this system attempts to prevent possible 
misclassifications by assigning a notation that 
specifies potential adverse effects. The skin no-
tation classification scheme presented within 
this CIB is as follows: 
 • SYS indicates the potential for a chemi-
cal to contribute substantially to systemic 
toxicity through dermal absorption.
 — (FATAL), a subnotation of SYS, 
indicates that a chemical is highly 
or extremely toxic, and may be 
potentially lethal or life-threatening 
following skin exposures. 
 • DIR indicates non-immune mediated di-
rect effect(s) of a chemical on the skin at or 
near the point of contact, including corro-
sion, primary irritation, bleaching (blanch-
ing), staining, and reduction/disruption of 
the skin barrier integrity. 
 — (IRR), a subnotation of DIR, 
indicates that a chemical is a skin 
irritant.
 — (COR), a subnotation of DIR, 
indicates that a chemical is a corrosive.
 • SEN indicates that skin exposure to a 
chemical may cause or contribute to the 
onset of allergic contact dermatitis (ACD) 
or other immune-mediated responses, 
such as airway hyper reactivity (asthma).
 • SK indicates that the reviewed data iden-
tified no health hazard associated with 
skin exposure and did not support assign-
ment of the SYS, DIR, or SEN notation.
 • ID(SK) indicates that insufficient data were 
available at time of evaluation to deter-
mine the hazards associated with dermal 
contact to a candidate chemical substance. 
 • ND indicates that a chemical has not been 
evaluated by the improved skin notation 
strategy, and the health hazards associ-
ated with skin exposure are unknown.
The new system also permits the assignment 
of several skin notations for a chemical when 
multiple skin hazards exist. For example, if 
health data indicate that the chemical causes 
systemic toxicity when absorbed by the skin 
and is also corrosive, the notation assigned to 
the chemical would be SK: SYS-DIR (COR). 
The skin notations may be modified or addi-
tional skin notations may be added when im-
proved scientific data on test methods and in-
creased understanding about the toxicological 
mechanisms of skin injuries become available. 
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Also, current criteria for assigning skin nota-
tions may be revised to enhance the usefulness 
of the notations for selecting exposure preven-
tion strategies. Hazard categories that are add-
ed later may follow the current scheme, which 
makes skin corrosives a subnotation under the 
DIR notation and acute lethality a subnotation 
under the SYS notation.
It should be noted that the strategy and skin 
notations outlined in this CIB are not intended 
to provide a risk-based exposure value for skin 
exposures to chemicals and should not be used 
to infer toxic potency for evaluated chemicals. 
Other issues associated with skin notations in-
clude their application to chemical mixtures, 
the health effects of contaminants within neat 
substances, and isomeric variations of a chemi-
cal. Because of the complexity of assessing the 
hazards of chemical interactions associated 
with complex mixtures or because of the pres-
ence of contaminants, the skin notations are 
intended to apply to neat chemicals and may 
not be health protective against additional ef-
fects associated with complex mixtures (see 
Appendix G.1). Also, assigned skin notations 
are applicable only to the specified forms of an 
evaluated compound and may not provide ad-
equate warnings about unique hazards of the 
nonspecified isomeric forms of the chemical 
(see Appendix G.1). 
The new skin notations will be included with-
in future NIOSH publications, including the 
NIOSH Pocket Guide to Chemical Hazards. 
Future versions of the NIOSH Pocket Guide 
to Chemical Hazards will have the skin nota-
tion assignments for each evaluated substance 
[e.g., SK: SYS-DIR (COR)] and an overview 
of the new skin notations. A separate publica-
tion called a Skin Notation Profile (see Appen-
dix F) will provide an in-depth summary of the 
 relevant data used to aid in determining the 
hazards associated with skin exposures.
2.1 Criteria for Assigning Skin 
Notations 
The critical step in assigning skin notations to a 
chemical is determining its hazard potential—
that is, its potential for causing adverse health 
effects as a result of skin exposure. This deter-
mination involves a health hazard identifica-
tion process that assesses the following:
 • Scientific data on the physicochemical 
properties of a chemical
 • Human exposures and health effects
 • Empirical data from in vivo and in vitro 
laboratory testing
 • The use of computational techniques, in-
cluding predictive algorithms [e.g., quan-
titative structure-activity relationships 
(QSAR)] and mathematical models that 
describe a selected process (e.g., skin per-
meation) using analytical or numerical 
methods. 
A weight-of-evidence approach is applied 
when available data are inconsistent. Figure 2 
illustrates the hierarchy of scientific data used 
for assigning skin notations. 
Computational techniques, such as mathemat-
ical models and predictive algorithms, repre-
sent alternative methods to expensive in vivo 
and in vitro toxicity testing methods. These ap-
proaches are increasingly applied to estimate 
the potential of chemicals to act as skin irri-
tants and sensitizers and their potential to be 
absorbed (i.e., skin permeation). The perfor-
mance and reliability of these computational 
techniques remain unclear. For this reason, 
predications from computational techniques, 
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such as QSARs and the skin dose to inhalation 
dose ratio (SI ratio) (see Appendix B), should 
not be used as the primary basis for the assign-
ment of a skin notation. Instead, they are in-
tended only to serve as additional supportive 
data sources when limited data are available for 
the assignment of skin notations. As the com-
putational techniques become more reliable 
and validated, NIOSH will reassess their use 
within the assignment of skin notations. If it is 
determined that the computational techniques 
accurately predict the effects of skin exposures 
to chemicals, they may become a primary basis 
for the assignment of skin notations.
The following sections discuss the skin nota-
tion assignments in each category. Exceptions 
to this approach are also described. This strat-
egy for assigning skin notations has been de-
veloped to correspond with the classification 
strategy adopted in the Globally Harmonized 
System of Classification and Labeling of Chemi-
cals (GHS) developed by the United Nations 
[UNECE 2005]. Appendix G.2 contains sup-
plemental information on the harmonization 
of the NIOSH skin notations with GHS. 
2.2 SYS
The SYS notation is assigned to chemicals that 
are absorbed through the skin and contribute 
to systemic toxicity. The (FATAL) subnotation 
is assigned to chemicals identified as highly or 
extremely toxic and potentially lethal or life-
threatening following skin exposure. The fol-
lowing are examples of adverse systemic effects 
that human and animal data have shown to be 
associated with skin exposures to chemicals 
with the assignment of the SYS notation or its 
subnotation (FATAL): 
 • Cardiotoxicity 
 • Carcinogenesis and photocarcinogenesis 
(excluding cancers of the skin) (see Ap-
pendix G.3)
 • Hematotoxicity 
 • Hepatotoxicity
 • Histopathological changes
 • Immunotoxicity
 • Lethality
Human health effec st
and exposure data
In vivo x city  to i udy data st
In vitro toxicity study data 
Computational techniques 
tical m eling a
redictive o
ath m o
g h
(M e a d nd
p al it mr s)
 
  
 
  
Figure 2. Hierarchy of evaluated scientific 
data
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 • Neurotoxicity
 • Nephrotoxicity
 • Reproductive and developmental effects
Systemic immune-mediated responses associ-
ated with exposures of the skin to chemicals 
are not assigned the SYS notation despite be-
ing systemic effects. These immune-mediated 
responses would be assigned the SEN notation 
if supportive data are identified, and they are 
addressed within Section 2.4. 
Standardized and widely accepted research 
protocols exist for using animals to test the sys-
temic toxicity of skin exposures to chemicals:
 • Protocols for testing chemicals developed 
by the Organization for Economic Coop-
eration and Development (OECD) and 
European Centre for the Validation of Al-
ternative Methods 
 • Health effects testing guidelines devel-
oped by the U.S. Environmental Protec-
tion Agency (U.S. EPA) Office of Preven-
tion, Pesticides, and Toxic Substances
 • Protocols established by the National 
Toxicology Program (NTP) for deter-
mining the prechronic toxicity and 
chronic toxicity/carcinogenesis of toxic 
substances 
Experimental toxicity studies using these pro-
tocols frequently result in quantitative data 
that can be used in assigning skin notations. 
The SYS notation is assigned to a chemical when 
one or more of the following criteria are met: 
 • Credible evidence indicates that systemic 
effects in workers result from skin expo-
sure to a chemical in the absence of sig-
nificant inhalation or oral exposures.
 • Data from experimental animal studies 
indicate—
 — Systemic effects occurred from skin 
exposures. 
 — Fatalities or health effects in exposed 
animals were not associated with 
skin damage by the chemical or the 
vehicle containing the chemical.
 — Skin exposure results for animals 
included data on acute toxicity, 
repeat-dose toxicity, subchronic 
toxicity, chronic toxicity, 
carcinogenicity, or biologic system/
function-specific effects. 
Appendix A describes the study protocols used 
and the criteria selected for assigning the SYS 
notation and its subnotations. 
 • Studies of scientific merit that followed 
protocols other than those previously 
identified and demonstrated systemic ef-
fects from skin exposure to a chemical. 
The protocols may be modifications of 
the standardized protocols with varia-
tions in the evaluation procedures, or 
they may be designs allowing for exami-
nation of health endpoints other than 
those the standardized protocols allow 
for. Examples of the latter studies include 
the following:
 — Investigation of the relevant 
toxicokinetics and potential 
toxic effects of metabolic 
transformation(s) of chemicals 
following skin absorption
 — Examination of the adverse 
effects of chemical mixtures with 
skin absorption or potential 
systemic toxicity different from 
the level anticipated for individual 
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components of the mixture because 
of synergistic effects
 — Investigation of altered skin 
permeability characteristics of toxic 
components resulting from the 
presence of a solvent or vehicle in a 
chemical preparation
 • If no acceptable-quality empirical data 
exist for systemic effects from skin expo-
sure to a chemical, systemic toxicity data 
may be extrapolated from toxicity data 
associated with other routes of exposure 
(such as oral and inhalation) when—
 — Quality toxicokinetics data 
demonstrate the ability of a chemical 
to be absorbed by the skin and
 — A direct link can be determined 
between the health effects caused by 
alternative routes of exposure and 
skin exposures. 
Both conditions must be satisfied to assign a 
SYS notation.
 • When no acceptable-quality empirical 
data exist on the systemic effects of skin 
exposure, the potential for dermal ab-
sorption and consequent systemic toxici-
ty of the chemical may be mathematically 
estimated via computational techniques. 
To mathematically determine the risk for 
systemic toxicity (e.g., predictive algo-
rithm), the following information is need-
ed: (1) skin permeation rate, (2) chemical 
dose calculated to be absorbed through 
skin (skin dose), (3) reference dose repre-
senting the threshold of acceptable body 
accumulation (a chemical dose to be ab-
sorbed via inhalation during the same pe-
riod of exposure), and (4) comparison of 
the skin dose to the reference dose (which 
indicates the significance of skin absorp-
tion and its potential contribution to sys-
temic toxicity). 
Appendix B presents an algorithm that can be 
used for determining the potential for systemic 
toxicity. When the predictive algorithm is used 
as the basis for identification, a positive result 
indicates that a chemical is capable of produc-
ing systemic toxicity from skin exposure and 
should be assigned the SYS notation. If the 
predictive algorithm indicates no potential for 
systemic toxicity from dermal absorption, the 
chemical should be further evaluated with ac-
cepted tests. The results of the predictive algo-
rithm should not be used as the sole basis of 
the assignment of a SYS notation. 
Table 2.2 provides an overview for the assign-
ment of the SYS notation based on the crite-
ria outlined within this section, in addition 
to Appendices A and B. Variables considered 
for the assignment of the SYS notation within 
this model include systemic toxicity associated 
with skin exposures and dermal absorption. 
Table 2.2 illustrates when the assignment of 
the SYS notation is appropriate based on the 
results of the critical review of all relevant sci-
entific data. 
2.3 DIR
Direct effects are non-immune mediated ad-
verse health effects resulting in damage or 
destruction of the skin localized at or near 
the point of contact. Most currently avail-
able reports on the direct effects of chemicals 
on skin (not immune-mediated) are related 
to irritation and corrosion and are qualitative 
descriptions summarized from the clinical 
observations of patients or the results of ex-
perimental animal studies. Manifestations of 
erythema and edema observed in humans and 
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in experimental animal studies are frequently 
used as indicators of skin irritation. Along with 
these reports, in vitro studies have shown that 
chemical contact with the skin may reduce 
the skin’s integrity as a barrier to penetration. 
Semiquantitative information can also be ob-
tained from irritation/corrosion testing such as 
the Draize patch test or its modifications [NAS 
1977]. Chemicals producing a direct effect on 
the skin that is not a result of an immune-me-
diated response are labeled SK: DIR. Chemi-
cals that are identified as irritants would be 
identified with the subnotation (IRR) [i.e., SK: 
DIR (IRR)]. Additionally, chemicals that cause 
necrosis of skin tissues or destruction of stra-
tum corneum following skin exposure would 
receive the subnotation (COR) [i.e., SK: DIR 
(COR)]. The following are examples of direct 
health effects on the skin that would result in 
the assignment of the DIR notation or one of 
its subnotations:
 • Carcinogenesis and photocarcinogenesis 
of the skin (see Appendix G.3) 
 • Changes in pigmentation including bleach-
ing (blanching) and staining of the skin
 • Chloracne
 • Compromise of the skin barrier integrity
 • Corrosion
 • Defatting or drying of skin
 • Irritant contact dermatitis
 • Phototoxicity
A chemical will be assigned the (IRR) subno-
tation when the reviewed data indicate that 
exposure of the skin to the substance causes 
reversible adverse effects, including inflam-
mation, dryness, or redness with minor pain 
or discomfort, at or near the point of con-
tact. The (COR) subnotation will be assigned 
when a chemical is known to cause irreversible 
Table 2.2. Overview for the assignment of the SYS notation
Systemic toxicity
D
er
m
al
 a
b
so
rp
ti
o
n
Yes No No data
Yes SYS* SYS† SYS‡
No SYS SYS SYS
No data SYS SYS No assignment§
*Indicates categories where the SYS notation would be assigned
†Indicates categories where the SYS notation would not be assigned
‡Assignment of the SYS notation is based on criteria outlined in NIOSH [2009]
§Indicates that insufficient data were identified to accurately assess the systemic hazards or 
potential for dermal absorption associated with contact of the skin with a specified chemical.
9NIOSH CIB 61 • Skin Notations
adverse effects accompanied by pain or dis-
comfort, such as tissue lesions or blisters, and 
burns of varying degrees at or near the point 
of contact. Skin irritants that are identified to 
cause corrosion will be assigned only the SK: 
DIR (COR) notation to ensure that the most 
hazards endpoint is recognized. 
Immune-mediated responses of the skin as-
sociated with exposures of the skin to chemi-
cals, such as ACD and allergic urticaria, are 
not assigned the DIR notation. These immune-
 mediated responses would be assigned the 
SEN notation if data are supportive and are ad-
dressed within Section 2.4.
An SK: DIR notation is assigned when one or 
more of the following criteria are met:
 • Credible evidence indicates that imme-
diate, prolonged, or repeated contact of 
skin with the chemical produces direct 
effects on the skin of exposed workers. 
The direct effects reported were based on 
incidents of worker exposures. The effects 
consist of the following:
 — Primary irritation, including irritant 
contact dermatitis (macroscopically 
manifested as erythema and edema) 
 — Corrosion (manifested as ulceration, 
visible necrosis of epidermis/dermis, 
bleeding, eschar formation, and 
discoloration)
 — Changed pigmentation
 — Chloracne caused by chemicals 
such as halogenated aromatic 
hydrocarbons
 — Defatting/drying of skin
 — Skin cancer at or near the point of 
contact
Predictive patch tests conducted on human 
volunteers (e.g., the acute dermal irritation 
study in human volunteers) may also yield in-
formation about acute or cumulative irritation 
of human skin [OECD 1997]. Such informa-
tion will be considered when assigning skin 
notations. 
 • Data from laboratory tests indicate direct 
effects on skin as a result of chemical ex-
posures. These data include in vivo ani-
mal studies reporting the acute irritancy, 
corrosivity, and carcinogenicity of chemi-
cals, in vitro assays identifying corrosivity 
potentials, and in vitro evaluations exam-
ining alteration in the barrier properties 
of skin as a result of skin exposure to 
chemicals. Appendix A describes proto-
cols and the criteria that can be used for 
deriving SK: DIR notations.
 • Relevant scientific data not generated using 
the study protocols previously described 
can be used if they provide adequate quali-
tative data on the direct effects on skin as a 
result of skin exposure to a chemical. Proto-
cols may be modifications of standardized 
protocols (e.g., the research protocols in-
troduced in Appendix A) with variations in 
the evaluation procedures or study design 
that examine health endpoints other than 
those evaluated by the standardized proto-
cols. Examples of the latter include reports 
of histopathological examinations indicat-
ing impairment of skin tissues, disintegra-
tion of skin components (e.g., defatting and 
discoloration), or the presence of neoplas-
tic lesions or tumors in the epidermis and 
dermis in association with changes in the 
transdermal penetration of chemicals. 
 • When no acceptable-quality empirical data 
exist on the direct effects of skin expo-
sure to a chemical, information from the 
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structure-activity-relationship  (SAR)-based 
analysis and the physicochemical proper-
ties and reactivity of the chemical may be 
used as alternative methods for identifying 
hazards [OECD 2001]. Examples of SAR 
analysis are the clinical and/or experimen-
tal observations of the adverse effects oc-
curring at the site of exposure to a structur-
ally related or similar chemical in question. 
Physicochemical properties such as extreme 
pH and buffering capacity can be used to 
estimate the corrosivity potential of acidic 
or alkaline chemicals on the skin. See Ap-
pendix C for further discussion about using 
pH and acid/alkali reserves for assigning 
SK: DIR notations. When the algorithm is 
used as the basis of identification, a positive 
result is sufficient to classify a chemical as 
capable of provoking direct effects on the 
skin and assigning an SK: DIR notation.
2.4 SEN
Skin exposure to a chemical may cause or con-
tribute to the onset of ACD or other immune-
mediated responses, such as airway hyper re-
activity (asthma). Occupationally, the most 
commonly recognized immune-mediated re-
sponses following skin exposure is ACD. For 
ACD, the skin-sensitizing potential of the chem-
ical is typically evaluated by two endpoints—the 
immunologic induction of sensitization and 
the elicitation of ACD. The SEN notation may 
be assigned to the following types of immune-
mediated responses caused by or contributed to 
exposures of the skin: 
 • ACD
 • Systemic allergic reactions
 • Immune-mediated respiratory diseases
Immune-mediated responses are commonly 
associated with two immune mechanisms: the 
immediate hypersensitivity response (which, in 
a previously sensitized person, normally occurs 
within minutes of exposure) and the delayed 
hypersensitivity response (which occurs 24–72 
hours following exposure). Immediate respons-
es are primarily mediated by immunoglobulin 
E antibodies when the chemical-specific anti-
bodies in systemic circulation contact antigens 
such as exogenous proteinaceous molecules. 
In the immediate hypersensitivity reaction, the 
respiratory tract, in addition to the skin, may 
respond after dermal exposure to the causative 
agent. Delayed hypersensitivity response is a 
 T-cell-mediated immune response that requires 
a procession of cellular events within the body 
(the induction phase) leading up to the inflam-
matory response (the elicitation phase). This 
procession includes (1) association of antigens 
(haptens) with proteins, (2) presentation of the 
protein- hapten conjugates to the regional lymph 
nodes, (3) recognition of the conjugates by spe-
cific T cells, and (4) proliferation of the specific 
T cells in draining lymph nodes. 
Results of animal and human studies support 
a link between exposures of the skin to certain 
chemical allergens, systemic sensitization, and 
the subsequent development of lung allergic 
responses following inhalational exposures 
[Kimber 1996; Beck and Leung 2000; Tinkle 
et al. 2003; Day et al. 2006; Bello et al. 2007; 
Kreiss 2007; Redlich and Herrick 2008; Pau-
luhn 2008]. Animal studies in several species 
have shown that skin exposure to isocyanates 
followed by inhalational challenge is highly ef-
fective at inducing asthmatic lung responses. 
[Bello et al. 2007; Pauluhn 2008]. Human stud-
ies, although more limited, suggest a similar 
role following skin exposure to certain sensitiz-
ing chemicals [Beck et al. 2000; Day et al. 2006; 
Kreiss et al. 2007; Redlich et al. 2008]. Despite 
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decreased inhalation exposures to isocyanates 
and beryllium within various occupational set-
tings, immune-mediated respiratory diseases 
associated with these compounds continue to 
occur, frequently in settings with opportunities 
for skin exposure [Bello et al. 2007; Kreiss et 
al. 2007; Redlich et al. 2008]. Together, the hu-
man and animal data suggest that skin contact 
with certain chemical allergens may contribute 
to the development of immune-mediated re-
spiratory diseases, such as asthma or chronic 
beryllium disease [Bello et al. 2007; Kreiss et al. 
2007; Redlich et al. 2008].
In laboratory testing, chemical allergens are 
largely identified in vivo using the conventional 
guinea pig sensitization test or the more inno-
vative murine local lymph node assay (LLNA). 
Data relevant for determining whether the 
chemical may cause an immune-mediated re-
sponse include the following [ECETOC 2002]:
 • Analytical or descriptive epidemiologic 
studies
 • Observational case reports from health 
surveillance programs and/or poison 
control centers 
 • Clinical studies 
Note—The main purpose of clinical tests with 
human volunteers is to confirm the safety of 
test materials or preparations rather than to 
identify skin sensitization hazards. 
The SEN notation is assigned when one or 
more of the following criteria are met:
 • Credible evidence indicates the occur-
rence of ACD or sensitization as a result of 
chemical exposure of the skin. Skin sensi-
tization among workers is often character-
ized clinically by immunologically medi-
ated cutaneous reactions such as pruritus, 
erythema, edema, papules, vesicles, bullae, 
or a combination of these findings. Infor-
mation about human  immune-mediated 
reactions from skin exposure may also be 
used from the results of predictive patch 
tests conducted on human volunteers (e.g., 
the human repeat insult patch test [ECE-
TOC 2000]). Such information will be 
considered when assigning skin notations. 
 • When human data are used as the basis of 
identification, one of the following types 
of evidence is sufficient to classify a sub-
stance as a sensitizer:
 — Studies in which sensitization 
is evident from valid clinical 
investigations (e.g., patch testing or 
antigen-specific immune responses, 
such as antibody responses or 
lymphocyte proliferation)
 — Confirmed case reports describing 
several subjects in more than one 
independent study
 — Epidemiologic evidence establishing 
a causal relationship between 
exposure and sensitization 
When only isolated episodes of ACD are ob-
served, supporting evidence should be ob-
tained (including data available from ani-
mal tests and an appropriate SAR) before the 
chemical is recognized as a contact allergen 
[European Commission 1996].
 • Animal data indicate the potential for 
ACD or other immune-mediated respons-
es associated with skin exposure. Such 
animal data include the guinea pig sensi-
tization tests identifying sensitization or 
ACD, LLNA, mouse ear swelling test, and 
relevant animal models of asthma. Appen-
dix A describes protocols and criteria that 
can be used in assigning the SEN notation. 
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 • Scientific data other than those previously 
described may be used to demonstrate 
sensitization as a result of skin exposure to 
a chemical. Such protocols include those 
that may be modifications of the standard-
ized protocols (e.g., the research protocols 
introduced in Appendix A) with variations 
in the evaluation procedures or study de-
signs that examine health endpoints other 
than those evaluated by the standardized 
protocols. An example is studies that eval-
uate the induction of antigen-mediated 
 responses following skin exposure.
 • When no empirical data of acceptable 
quality exist, the occurrence of ACD or 
other immune-mediated responses as a 
result of skin exposure to a chemical, in-
formation from the SAR-based analysis, 
and other computational techniques can 
be used as alternative methods for identi-
fying hazards. An example of a SAR anal-
ysis is the use of the knowledge-based ex-
pert system Deductive Estimation of Risk 
from Existing Knowledge (DEREK™) 
to evaluate the relationship between the 
molecular structure of the chemical and 
its allergenic properties. Appendix C de-
scribes the DEREK™ expert system for 
identifying sensitizers. When the algo-
rithm is used as the basis of identification, 
a positive result is sufficient to classify a 
chemical as an agent capable of provok-
ing ACD or sensitization from skin expo-
sure and assigning the SEN notation. 
2.5 SK
The SK notation is assigned to indicate that 
a chemical underwent a critical assessment, 
based on the criteria described above, of the 
scientific data and was not identified as a sys-
temic, direct, or sensitizing health risk from 
skin exposure. It should be noted that for a 
chemical to be assigned the SK notation, the 
scientific data must be classified as sufficient 
based on the criteria outlined in Appendix E. 
2.6 ID(SK) 
The ID(SK) notation indicates that insufficient 
data exist on the health hazards associated with 
skin exposures to a substance to determine if the 
chemical has the potential to act as a systemic, di-
rect, or sensitizing agent. Assignment of this no-
tation will be determined through an assessment 
of a chemical’s creditable scientific data identified 
during an extensive search of published literature 
(see Appendix E). Chemicals designated with 
the ID(SK) notation may represent a significant 
health hazard following contact with the skin, 
and proper controls should be applied to prevent 
or minimize occupational exposures. Despite the 
absence of sufficient data to assign the SYS, DIR, 
or SEN notation, a Skin Notation Profile (see 
Appendix F) will be drafted for all chemicals as-
signed ID(SK) to document that the substance has 
been previously evaluated. 
 2.7 ND
The ND notation signifies that a chemical has 
not been evaluated by the strategy outlined in 
this CIB, and the associated health hazards of 
skin exposure are unknown. The ND notation 
will be included within future NIOSH publi-
cations, including the NIOSH Pocket Guide to 
Chemical Hazards. 
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This appendix presents the experimental pro-
tocols used in laboratory studies of the sys-
temic effects, direct effects on skin, and sensi-
tization potentials of chemicals resulting from 
skin exposure using animal models or alter-
native methods (e.g., in vitro bioassays). The 
protocols included have generally been stan-
dardized and validated by various regulatory 
agencies and research institutes in the United 
States and Europe. For each protocol, the in-
troduction contains (1) concise discussions of 
the underlying principles and methods and 
(2) criteria for assigning skin notations based 
on results of studies that followed the protocol. 
As the investigative methods are developed or 
improved, other protocols with scientific merit 
may become available. Depending on their sta-
tus, additional protocols may be selected to de-
velop criteria for assigning skin notations.
A.1 Experimental protocols 
for investigating systemic 
effects of skin exposure 
and derived criteria for 
assigning the SYS notations
A.1.1 Dermal absorption
Dermal absorption is the transport of chemicals 
from the outer surface of the skin both into the 
skin and into systemic circulation. This process 
is often described using the terms penetration, 
permeation, and resorption. Experimental tech-
niques used to estimate the potential for absorp-
tion include in vivo and in vitro toxicity studies 
and computational techniques. 
In vivo and in vitro test methods have been de-
veloped to estimate both the rate and percent-
age of an applied dose of a substance absorbed 
(i.e., penetration or permeation) through the 
skin [OECD 2004a,b,c; IPCS 2006]. In vivo 
studies use a physiologically and metabolically 
active system in the form of human volunteers 
or test animals, such as rats, to assess the skin 
penetration, permeation, and resorption of 
test chemicals [OECD 2004a; OECD 2004c; 
IPCS 2006]. In vitro dermal absorption tests 
generally rely on the application of a radiola-
belled test substance to a sample of nonviable 
or metabolically active excised skin suspended 
between two chambers of a diffusion cell and 
are used to measure the rates of penetration 
and permeation [Bronaugh and Stewart 1985; 
U.S. EPA 2004; OECD 2004b]. In both in vivo 
and in vitro experimental studies, the applied 
dose and the vehicle may directly influence the 
absorption of the substance across the skin. 
Computational techniques, such as QSARs and 
QSPR, have been developed to offer a relatively 
inexpensive method for determining skin pen-
etration of chemicals [Moss et al. 2002; Riviere 
and Brooks 2005; IPCS 2006]. The predictive 
APPENDIX A • Protocols Used in Studies of 
Health Effects from Skin Exposure and the 
Determination of Criteria Derived for Assigning 
Skin Notations
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algorithms use the physicochemical properties 
(i.e., molecular weight, solubility, pH) of a test 
substance to estimate the potential biologic ef-
fects or transport properties within a biologic 
system [Moss et al. 2002; Riviere and Brooks 
2005; OECD 2004a; IPCS 2006]. 
The results of dermal absorption tests are fre-
quently presented as the estimated or predicted 
percentage (%) of the applied dose absorbed. 
To differentiate between low and high dermal 
absorption, a 10% absorption rate has been se-
lected as the critical cutoff value. This value cor-
responds to OECD guidelines [OECD 2004a] 
and is based on recommendations proposed by 
the Netherlands Organization for Applied Sci-
entific Research (TNO) [De Heer et al. 1999]. 
If the dermal absorption rate values reported 
within reviewed data are consistently higher 
than 10%, the chemical is considered to have 
a high potential for dermal absorption and to 
contribute to systemic dose. 
A.1.2 Acute toxicity
Acute toxicity testing examines the mortality 
of test animals after single, short-term expo-
sures to a toxic chemical [OECD 1987; U.S. 
EPA 1998a]. Typically, the test chemical is 
applied to the skin and remains in place for 
24 hours. The animals are then observed for 
14 days. The results of acute toxicity tests are 
presented as the dose that is lethal to 50% of 
the exposed animals (LD50) following applica-
tion of the chemical to the skin, with obser-
vations of behavioral/clinical abnormalities 
and pathologic findings from gross necropsy. 
If the LD50 values are consistently lower than 
the critical cutoff value of 2000 milligrams of a 
substance/kilograms animal body weight (mg/
kg), the chemical is considered systemically 
toxic by the dermal route and is assigned the 
SYS notation. The critical value of 2000 mg/kg 
for the dermal LD50 reflects the dose selected in 
standardized limit tests to identify chemicals 
with the potential for acute toxicity. This value 
corresponds with the upper LD50 limit for es-
tablishing a chemical as harmful in the general 
classification and labeling requirements for 
chemicals in member countries of the OECD 
[Council of the European Communities 1992] 
and by GHS [UNECE 2005]. 
If LD50 values are consistently lower than the 
critical cutoff value of 200 mg/kg of animal 
body weight, the chemical is potentially lethal 
or life-threatening following acute exposures 
of the skin and is assigned the (FATAL) nota-
tion. This value is consistent with the numeric 
cutoff value used by GHS to identify chemicals 
capable of causing death following contact with 
the skin (see Appendix G.2.). 
A.1.3 Repeat-dose toxicity
Repeat-dose toxicity testing examines the toxic 
effect(s) of repeated exposure of the skin to 
a chemical for 21 or 28 days [OECD 1981a; 
U.S. EPA 1998b]. The animals are observed 
for behavioral and clinical abnormalities dur-
ing the study. At the end of the study, they are 
examined for gross organ lesions, hematology, 
clinical chemistry, ophthalmology, and his-
topathology. Test results often include the re-
porting of a  no-observed-adverse-effect level 
(NOAEL) as the most sensitive endpoint(s) 
selected from all evaluated health effects. If 
the NOAEL for a selected endpoint is lower 
than the critical cutoff value of 1000 mg/kg as 
a daily dose ( mg / kg-day), the chemical is con-
sidered systemically toxic by the dermal route 
and is assigned the SYS notation. The critical 
NOAEL value of 1000  mg / kg-day reflects the 
dose selected in the standardized limit tests 
to identify chemicals with the potential for 
repeat-dose toxicity following contact with the 
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skin. If a creditable NOAEL is not identified 
within the reviewed toxicological data, other 
toxicity threshold measurements, such as the 
lowest-observed-adverse-effect level (LOAEL), 
lowest-observed-effect level (LOEL), or no- 
observed-effect level (NOEL), may be substi-
tuted for comparison with the critical cutoff 
value of 1000 mg/kg-day. 
A.1.4 Subchronic toxicity 
Subchronic toxicity testing examines the cu-
mulative toxic effect(s) from continuous or 
repeated exposure of the skin to a chemical 
for at least 90 days [OECD 1981b; U.S. EPA 
1998c]. The animals are observed for behav-
ioral/clinical abnormalities during the study. 
At the end of the study, they are examined for 
gross organ lesions, hematology, clinical chem-
istry, ophthalmology, and histopathology. Test 
results often include the NOAEL for the most 
sensitive endpoint(s) selected from all evalu-
ated health effects. If the NOAEL for a selected 
endpoint is lower than the critical cutoff value 
of 1000  mg / kg-day, the chemical is considered 
systemically toxic by the dermal route and is 
assigned the SYS notation. The critical NOAEL 
value of 1000 mg/kg-day reflects the dose se-
lected in the standardized limit tests to identify 
chemicals with the potential for subchronic 
toxicity following contact with the skin. If a 
creditable NOAEL is not identified within the 
reviewed toxicological data, a LOAEL, LOEL, 
or NOEL may be substituted when available 
for comparison to the critical cutoff value of 
1000 mg/kg-day. 
A.1.5 Chronic toxicity 
Chronic toxicity testing examines the cumula-
tive toxic effect(s) of continuous or repeated 
exposure of a chemical to the skin for at least 12 
months [OECD 1981c; U.S. EPA 1998d]. The 
animals are observed for behavioral/clinical 
abnormalities during the study. They are evalu-
ated using hematology, clinical chemistry, uri-
nalysis, and ophthalmology during and at the 
end of the study. At necropsy, they are exam-
ined for gross organ lesions and tissue histopa-
thology. Test results often include the NOAEL 
for the most sensitive endpoint(s) selected 
from all evaluated health effects. If the NOAEL 
for a selected endpoint is lower than the critical 
cutoff value of 1000  mg / kg-day, the chemical is 
considered systemically toxic following skin 
exposure and is assigned the SYS notation. The 
critical cutoff value of 1000  mg / kg-day reflects 
the dose selected in the standardized limit tests 
to identify chemicals with the potential for 
chronic toxicity following contact of the skin. 
If a creditable NOAEL is not identified with-
in the reviewed toxicological data, a LOAEL, 
LOEL, or NOEL may be substituted when avail-
able for comparison to the selected cutoff value 
of 1000 mg/kg-day. 
A.1.6 Carcinogenicity
Carcinogenicity testing examines the develop-
ment of neoplastic lesions or tumors in organs 
and tissues—excluding the skin (see Section 
A.2.3)—as a result of long-term exposure of the 
skin to a chemical for 18–24 months [OECD 
1981d; U.S. EPA 1998e]. The test period con-
stitutes a substantial portion of the lifespan 
of test animals. The animals are observed for 
behavioral/clinical abnormalities during the 
study. They are investigated for clinical pathol-
ogy during and at the end of the study and for 
gross organ lesions and tissue histopathology 
at necropsy. Carcinogenicity from skin expo-
sure to a chemical may be studied and reported 
jointly with chronic toxicity following expo-
sures of the skin [OECD 1981e; U.S. EPA 1998f; 
NTP 2001a]. Other systemic toxicants in this 
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category are chemicals reported to cause pho-
tocarcinogenesis (the elicitation or increase 
of a toxic and/or carcinogenic response after 
dermal absorption and subsequent exposure 
to sunlight) [NIH 2002a; OECD 2004d]. If a 
candidate chemical is determined to produce 
a statistically significant increase in the inci-
dence of neoplastic lesions or tumors in test 
animals, it is considered to be carcinogenic and 
assigned the SYS notation.
A.1.7 Toxic effects of exposures of 
the skin on organ systems or 
biologic functions 
Several types of tests allow for the examina-
tion of the destruction or disruption of target 
organ systems and/or biologic functions from 
skin exposure to chemicals. Examples include 
(1) prenatal development toxicity (maternal 
and fetal toxicity) testing [U.S. EPA 1998g; 
NTP 2001b; OECD 2001a], (2) two-generation 
reproduction and fertility effects testing [U.S. 
EPA 1998h; OECD 2001b], and (3) immuno-
toxicity (suppression of the immune system) 
testing [U.S. EPA 1998i]. Ideally, a NOAEL is 
identified and reported for the studied effect(s). 
If the NOAEL for selected endpoint(s) is lower 
than 1000 mg/kg-day, the chemical is consid-
ered systemically toxic by the dermal route and 
assigned the SYS notation. The critical cutoff 
value of 1000 mg/kg-day reflects the dose se-
lected in the standardized limit tests used to 
identify chemicals that are potentially toxic to 
organs or biologic functions following contact 
with the skin. In the event that a NOAEL can-
not be identified within reviewed toxicological 
data, a LOAEL, LOEL, or NOEL may be sub-
stituted when available for comparison to the 
critical cutoff value of 1000 mg/kg-day. 
A.1.8 Assignment of the SYS 
notation based on alternative 
exposure pathways
Toxicity data associated with alternative expo-
sure pathways (i.e., ingestion, inhalation, and 
injection) may be considered during the as-
signment of the SYS notation. The primary cri-
teria applied for determining the appropriate-
ness of the use of toxicity data associated from 
alternative exposure pathways are as follows:
1. No quality dermal toxicity data were iden-
tified.
2. Toxicokinetics data clearly demonstrate 
that the chemical has a high potential to 
be dermally absorbed and contributes 
significantly to systemic dose (see Section 
A.1.1).
3. The critical health endpoint(s) being in-
vestigated must be systemic in nature.
4. The critical systemic endpoint(s) is inde-
pendent of the route of exposure.
A.2 Experimental protocols 
for investigating direct 
effects of skin exposure 
and derived criteria for 
assigning the DIR notations
A.2.1 In vivo animal tests for acute 
irritancy and corrosivity
Most research protocols available for in vivo 
testing for skin irritation and corrosion fol-
low the Draize procedure, with modifications 
in exposure duration, test animal species and 
number, and intervals between observations. 
In the standardized protocols [U.S. EPA 1998j; 
OECD 2002a], a single dose of the test chemical 
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is applied to the skin of albino rabbits, normally 
for 4 hours unless corrosion is observed. The 
animals are examined for signs of erythema and 
edema, and the responses are scored at intervals 
over 72 hours. These procedures are also used 
to examine and grade any persistent or delayed 
effects that may occur within 14 days after expo-
sure and to fully evaluate the reversibility of ob-
served effects. A chemical that induces reversible 
inflammation, dryness, or redness with minor 
pain or discom fort of the skin is considered 
an irritant and is assigned the (IRR) notation. 
The (COR) subnotation will be assigned when a 
chemical is known to cause irreversible adverse 
effects accompanied by pain or discomfort, such 
as tissue lesions or blisters, and burns of varying 
degrees at or near the point of  contact. 
A.2.2 In vitro tests for corrosivity using 
human or animal skin models 
In vitro methods using human or animal skin 
models are used as alternatives to convention-
al in vivo tests for assessing the corrosivity of 
chemicals. The following methods have been 
standardized by the OECD as guidelines for 
testing of chemicals and peer-reviewed and 
recommended for regulatory acceptance by 
the Interagency Coordinating Committee on 
the Validation of Alternative Methods (ICC-
VAM) and the NTP Interagency Center for the 
Evaluation of Alternative Toxicological Meth-
ods (NICEATM):
 • Corrositex® [NIH 1999a]
 • The human skin models [OECD 2004e], 
including EPISKIN™ and EpiDerm™ [NIH 
2002b]
 • The rat skin transcutaneous electrical re-
sistance (TER) assay [NIH 2002b; OECD 
2004f]
The Corrositex® assay evaluates the pH-sensitive 
destruction of a reconstituted, collagen-based 
biobarrier and determines the corrosivity poten-
tial by measuring the time required for the test 
material to pass through the biobarrier mem-
brane (i.e., the breakthrough time) and produce 
a visually detectable change in the Chemical De-
tection System. Chemicals of high acid/alkaline 
reserves (Category I materials) and those of low 
acid/alkaline reserves (Category II materials) are 
considered corrosive when their breakthrough 
times are less than 4 hours and 1 hour, respec-
tively [Fentem et al. 1998; U.S. EPA 1996]. The 
EPISKIN™ and EpiDerm™ models evaluate the 
corrosivity potential of a test substance by mea-
suring the decreased viability of human skin cells 
in reconstructed epidermis/dermis after expo-
sure. In EPISKIN™, a test substance is identified 
as potentially corrosive when it induces at least a 
35% decrease in cell viability. In EpiDerm™, the 
substance is classified as corrosive if it induces at 
least a 50% decrease in relative cell viability after 
3 minutes of exposure or at least an 85% decrease 
after 60 minutes. The TER assay measures the re-
duction of inherent TER on the skin of young rats 
caused by the loss of normal stratum corneum 
integrity and barrier function. A test substance is 
considered potentially corrosive and assigned the 
(COR) notation if it reduces the TER to a thresh-
old below 5 kilohms. 
A.2.3 Carcinogenicity
Carcinogenicity testing examines the develop-
ment of neoplastic lesions on skin as a result of 
long-term exposure of the skin to a chemical for 
18–24 months [OECD 1981d; U.S. EPA 1998e]. 
The test period constitutes a major portion of 
the life span of test animals. The animals are 
observed for behavioral/clinical abnormalities 
during the study. They are investigated for clini-
cal pathology during and at the end of the study. 
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They are also examined for gross organ lesions 
and tissue histopathology at necropsy. Carcino-
genicity from skin exposure to a chemical may 
be studied and reported jointly with chronic 
toxicity of the skin [OECD 1981e; U.S. EPA 
1998f; NTP 2001a]. If skin exposure to a chemi-
cal induces a statistically significant increase in 
the incidence of neoplastic lesions or tumors in 
test animals, it is considered to be a potential 
skin carcinogen and is assigned the DIR nota-
tion. Additionally, chemicals identified as being 
capable of causing photocarcinogenesis when 
topically applied in conjunction with exposure 
to sunlight will be included within this category 
[NIH 2002a; OECD 2004d].
A.2.4 In vitro tests of skin integrity 
using human donor skin 
Examples of in vitro methods for evaluating 
skin integrity include those for measuring the 
movement of a standard compound such as 
tritiated water through the stratum corneum, 
the transepidermal water loss from the stra-
tum corneum, and the electrical resistance of 
skin to an alternating current at up to 2 volts 
[OECD 2004a,b]. 
A.3 Experimental protocols for 
investigating sensitization 
from skin exposure 
and derived criteria for 
assigning the SEN Notation
A.3.1 Identifying skin sensitization 
or ACD with guinea pig test 
methods
Standardized guinea pig test methods include 
the guinea pig maximization test and the Bue-
hler test [OECD 1992; U.S. EPA 2003]. In these 
tests, the animals are initially exposed to the 
test substance by intradermal injection and/or 
epidermal application to induce an immune re-
sponse. After 10–14 days, the animals receive a 
challenge exposure to the test substance to es-
tablish whether a hypersensitive state has been 
induced. The disease-analogous skin reactions 
(e.g., local irritation in the forms of erythema/
edema) following the challenge exposure are 
measured and graded (usually 24 and 48 hours 
post challenge) to determine the degree of skin 
sensitization or ACD. A chemical that induces 
allergic skin reactions is considered a sensitizer 
and is assigned the SEN notation.
A.3.2 Identifying skin sensitization 
potential with the murine 
local lymph node assay 
The murine LLNA has been peer-reviewed by 
ICCVAM and the NICEATM panel and rec-
ommended for regulatory acceptance [NIH 
1999b]. OECD [2002b] and U.S. EPA [2003] 
have adopted this assay as a standard test meth-
od for evaluating the skin sensitization poten-
tial for chemicals. The LLNA determines the 
induction of skin sensitization by identifying 
cell proliferation in the lymph node that drains 
the site of chemical application. The LLNA 
also provides quantitative data for assessing 
the dose-response relationship. In the test, cel-
lular proliferation is measured as a function 
of in vivo radioisotope incorporation into the 
deoxyribonucleic acid (DNA) of dividing lym-
phocytes. The ratio of lymphocyte proliferation 
in treated groups to that in vehicular controls 
(stimulation index) is determined to serve as 
a quantitative criterion. A substance is consid-
ered a sensitizer and assigned the SEN notation 
if it has a statistically significant stimulation in-
dex greater than or equal to 3 and is supported 
by a fitting dose-response relationship.
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A.3.3 Identifying skin sensitization 
potential with the mouse ear 
swelling test 
The mouse ear swelling test (MEST) [Gad et 
al. 1986; Thorne et al. 1991a,b] is accepted by 
OECD [1992] and U.S. EPA [2003] as a screen-
ing test for detecting chemicals with sensitiza-
tion potential. In the noninvasive MEST, the an-
imals are initially exposed to the test substance 
by topical application on the abdomen to in-
duce an immune response. After the induction 
period, the test substance is applied topically to 
the ears of animals (challenge exposure). Ear 
thickness as a function of swelling is measured 
at 24-hour intervals for 2–3 days post challenge 
to determine whether a delayed hypersensitivity 
has occurred. A chemical is considered a sen-
sitizer if it yields a positive result in the MEST. 
If this test indicates no sensitization potential, 
the chemical should be further examined with 
an accepted test such as the guinea pig sensitiza-
tion test or the LLNA [U.S. EPA 2003] before the 
substance is considered a nonsensitizer. 
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B.1 Algorithm for estimating 
and evaluating skin 
exposure hazards
Appendix B presents a predictive algorithm for 
estimating and evaluating the health hazards 
of skin exposure to chemicals. The algorithm is 
designed to evaluate the potential for a chemi-
cal agent to penetrate the skin and induce sys-
temic toxicity. The goals for incorporating this 
algorithm into the proposed strategy for as-
signing SYS notation are as follows: 
 • Provide an alternative method to evaluate 
chemicals for which no clinical reports or 
animal toxicity studies exist or for which 
empirical data are insufficient to deter-
mine systemic effects 
 • Use the algorithm evaluation results to 
determine whether a chemical poses a 
skin absorption hazard and should be la-
beled with the SYS notation
The algorithm evaluation includes three steps: 
1. Determining a skin permeation coeffi-
cient for the chemical
2. Estimating chemical uptake by the der-
mal and respiratory absorption routes
3. Evaluating whether the chemical poses a 
skin exposure hazard. 
The algorithm is flexible in the data require-
ment and can operate entirely on the basis of the 
physicochemical properties of a chemical and 
the relevant exposure parameters. Thus, the al-
gorithm is independent of the need for biologic 
data. Or, it can function using both the physi-
cochemical properties and the experimentally 
determined permeation coefficients when the 
latter data are available and appropriate to use. 
B.1.1 Step 1: Determining the skin 
permeation coefficient
The first step in the evaluation is to determine 
the skin permeation coefficient (Kp) for the 
chemical to describe the transdermal penetra-
tion rate of the substance. The Kp determined 
for a chemical is expressed in cm/hr and rep-
resents the overall diffusion of the substance 
through the stratum corneum and into the 
blood capillaries of the dermis. This value may 
be determined from laboratory tests or by 
QSPR or QSAR. 
Experimentally, the permeation of chemicals 
through human skin can be determined in vitro 
using diffusion cell techniques such as those de-
scribed in the protocols standardized by OECD 
[2004a,b] and U.S. EPA [69 Fed. Reg.† 22402 
(2004)]. These methods typically  measure the 
†Federal Register. See Fed. Reg. in references.
APPENDIX B • Algorithm for estimating skin 
absorption and systemic toxicity and suggested 
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diffusion of a test substance into and across 
the excised skin (which consists of epidermal 
membranes or split-thickness skin) to a fluid 
reservoir; they report the Kp as a quantitative 
measurement of the rate of skin diffusion at the 
steady state when an infinite dose is employed. 
Measured Kp values from the actual workplace 
vehicle should be used when available. The ex-
perimentally determined Kp values are not al-
ways available or generated following standard-
ized protocols. An alternative approach is to use 
the QSPRs that predict the Kp of chemicals based 
on the physicochemical properties relevant to 
their transport behavior in the stratum cor-
neum, such as the molecular size and solubility 
in the lipids of the stratum corneum. Vigorous 
research in the modeling of skin permeation 
has led to the development of various validated 
QSPRs—for example, the refined Potts and Guy 
equation [U.S. EPA 2004], the revised Robinson 
model [Wilschut et al. 1995], and the Random 
Walk model [Frasch 2002]. 
As an example to demonstrate the determi-
nation of Kp by predictive QSPRs, the revised 
Robinson model is presented here for its math-
ematical descriptors and operation. The revised 
Robinson model has been shown to be among 
the QSPRs that provide reasonable Kp esti-
mates when compared with the experimentally 
derived values [Wilschut et al. 1995; Vecchia 
and Bunge 2003]. The revised Robinson model 
estimates Kp based on the molecular weight of 
a chemical (MW, representing the molecular 
size) and the logarithm of its octanol-water 
partition coefficient (log KOW, representing the 
hydrophobicity). This model is mathematically 
expressed as follows:
where Kpsc is the permeation coefficient in the 
lipid fraction of the stratum corneum, Kpol is 
the coefficient in the protein fraction of the 
stratum corneum, and Kaq is the coefficient in 
the watery epidermal layer. These components 
are individually estimated by 
log Kpsc  =  −1.326 + 0.6097 × log KOW −  
0.1786 × MW0.5
Kpol  =  0.0001519 × MW
−0.5
Kaq  =  2.5 × MW
−0.5
Exercising caution is important when a QSPR 
is used in the derivation of Kp. Many of the em-
pirical QSPRs, which are constrained by the 
experimental data used in the development 
and validation, are subject to limitations in the 
types of chemicals to which the models may 
apply. These QSPRs may not provide reliable 
Kp estimates for inorganic substances, ionized 
substances, very high-MW chemicals, small 
hydrophilic molecules, or highly volatile sub-
stances. Chemicals in the first three categories 
are not readily absorbed through the skin, and 
their experimental Kp values are often not read-
ily available for model validation. Hydrophilic 
substances of small MW tend to penetrate hair 
follicles and sweat glands and, therefore, are 
not sufficiently covered in the assumed path-
way of penetration by many models. Also, with 
a few exceptions, the QSPRs typically do not 
account for the evaporation of chemicals from 
the skin; as a result, the predicted Kp for vola-
tile substances could be overstated.
B.1.2 Step 2: Estimating chemical 
uptake from skin and 
inhalation exposures
Step 2 in the evaluation (as initially proposed by 
the Toxic Substances Control Act Interagency 
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Testing Committee [Walker et al. 1996]) is to 
calculate the biologic uptake of the chemical 
from skin absorption (skin dose) and inhala-
tion (inhalation dose) during the same period 
of exposure. The inhalation dose represents a 
critical presence of the examined substance 
in the body. Beyond this dose, bioaccumula-
tion of the substance is a cause for concern for 
health effects. The skin and inhalation doses 
provide quantifiable measures for absorption 
of the chemical by different routes. These doses 
serve as the basis for determining whether the 
substance constitutes a skin absorption hazard.
The skin dose is calculated as a mathematical 
product of the Kp acquired in Step 1, the water 
solubility (SW) of the chemical, the exposed skin 
surface area, and the duration of exposure. In 
the calculation, the transdermal flux of the sub-
stance is assumed to originate from a saturated 
aqueous solution. Assuming that the skin expo-
sure continues for 8 hours to unprotected skin 
on both palms (a surface area of 360 cm2), 
Skin dose  =  Kp × SW × Exposed skin 
 surface area × Exposure time
 =  Kp (cm/hr) × SW (mg/cm
3) × 
 360 cm2 × 8 hr
The inhalation dose is derived on the basis of 
the occupational exposure limit (OEL) of the 
substance—if the OEL is developed to prevent 
the occurrence of systemic effects rather than 
sensory/irritant effects or direct effects on the 
respiratory tract. Assuming a continuous expo-
sure of 8 hours, an inhalation volume of 10 m3 
in 8 hours, and a factor of 75% for the retention 
of the airborne substance in the lungs during 
respiration (retention factor, RF), 
Inhalation dose  =  OEL × Inhalation volume 
 × RF
 =  OEL (mg/m3) × 10 m3 × 
 0.75
In the above equation, a default value of 0.75 
is used for the RF to represent the respiratory 
retention of chemicals. The percentage value 
for the absorption of xenobiotics via the lungs 
is commonly assumed to be 75%–100% [Euro-
pean Chemicals Bureau 2003], and the default 
RF of 0.75 is selected to avoid underestimating 
skin absorption as a significant route of bio-
logic uptake because complete absorption is 
unlikely to occur for most chemicals inhaled 
into the lungs. When scientifically justified, 
chemical-specific RFs may be used in place of 
the default value, especially for chemicals with 
systemic bioavailability lower than the default 
value (e.g., because of the extensive metabo-
lism of substances in the lungs or accumula-
tion in the blood leading to absorption that is 
no longer perfusion limited).
B.1.3 Step 3: Evaluating the skin 
exposure hazard
The final step is to compare the calculated skin 
and inhalation doses and to present the result 
as a ratio of skin dose to inhalation dose (the 
SI ratio). This ratio quantitatively indicates 
(1) the significance of dermal absorption as 
a route of occupational exposure to the sub-
stance and (2) the contribution of dermal up-
take to systemic toxicity. If a chemical has an SI 
ratio greater than or equal to 0.1, it is consid-
ered a skin absorption hazard.
B.2 Criterion for assigning the 
SYS notations 
The SYS notation will be assigned to a chemi-
cal when the mathematical evaluation indicates 
an SI ratio of at least 0.1 and when no data of 
scientific merit suggest that the potential health 
effects exclude systemic effect(s). An SI ratio of 
0.1 is selected as the reference level based on a 
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recent examination of chemicals recognized 
as skin absorption hazards by NIOSH. In this 
examination, SI ratios were calculated for 108 
chemicals; all chemicals had assigned NIOSH 
skin notations, and the literature suggested them 
to be agents of systemic toxicity following skin 
exposure. Approximately 76% of the examined 
substances had SI ratios greater than 0.1. This 
result suggests that a chemical be treated as a 
skin absorption hazard when its dermal uptake 
exceeds 10% of its uptake by inhalation. The re-
sult also supports an SI ratio of 0.1 as the thresh-
old value for assigning SYS notation. For the 
24% of examined substances predicted to have 
an SI ratio less than 0.1, the preliminary analysis 
indicates that two factors may have contributed 
significantly to the low ratio:
 • The OELs used to calculate inhalation 
dose were initially developed with a small 
safety margin compared with the OELs 
for substances having an SI ratio greater 
than 0.1.
 • The health effects basis for skin notations 
may not be adequate. 
These factors are being further investigated 
as a part of the ongoing NIOSH effort to re-
evaluate the health effects of skin exposure to 
these chemicals using scientifically up-to-date 
data. Results of these analyses will be used to 
improve the NIOSH skin notations.
This criterion agrees with the findings from 
similar research conducted by other interna-
tional occupational safety and health organi-
zations. One example is the proposal of the 
European Centre for Ecotoxicology and Toxi-
cology of Chemicals (ECETOC) to recom-
mend skin notations based on a semiquantita-
tive approach [ECETOC 1998]. The algorithm 
proposed by ECETOC is similar to the one 
intended for assigning NIOSH SK: SYS nota-
tions. The ECETOC algorithm determines the 
skin exposure hazard posed by a chemical agent 
by comparing its dermal uptake to its systemic 
absorption from inhalation. ECETOC con-
cluded that a skin notation should be assigned 
to a chemical when the amount of chemical ab-
sorbed by both hands and forearms in 1 hour 
could exceed 10% of the amount absorbed by 
inhalation when airborne concentrations are 
at the OEL for 8 hours. The defaults of the 
exposed skin surface area, the air volume in-
haled in 8 hours, and the respiratory RF in the 
ECETOC algorithm are 2000 cm2, 10 m3, and 
50%, respectively. The SI ratio calculated in 
the algorithm proposed for recommending the 
NIOSH SK: SYS notations (SI ratioNIOSH) can be 
modified to derive an SI ratio according to the 
method proposed by the ECETOC (SI ratioECE-
TOC). A comparison between the SI ratioNIOSH 
and the SI ratioECETOC reveals that
SI ratioECETOC = SI ratioNIOSH × [2000 cm
2 (hands
 and arms) ÷ 360 cm2 (palms)] × 
 (1 hr ÷ 8 hr) × [75% (default  
 RF in NIOSH algorithm) ÷ 50%  
 (default RF in ECETOC  
  algorithm)] = SI ratioNIOSH × 1.04
This comparison shows that for any chemical 
where the modeling approach may be applied, 
the SI ratio determined using the algorithm for 
assigning the SYS notation is approximately the 
same as the SI ratio generated by following the 
assumptions made in the algorithm proposed 
by ECETOC. Similarly, in both methods, the 
criteria for determining the health hazard of a 
skin exposure are based on essentially the same 
level of skin absorption.
In view of these findings, dermal absorption 
of a chemical is considered a systemic toxic-
ity hazard if the substance is evaluated by the 
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algorithm as demonstrated in this appendix 
and is shown to have an SI ratio greater than 
0.1. The SYS notation will be assigned ac-
cordingly. For these substances, additional 
toxicological evaluations are recommended to 
clinically or experimentally verify the adverse 
systemic effect(s).
Note that in the context of Appendix B, the 
predictive algorithm is intended to serve as 
a hazard identification tool for determining 
whether skin exposure to a chemical agent is 
inherently capable of provoking systemic tox-
icity and is supportive of assigning the SYS no-
tation. The SI ratio of 0.1 was determined as 
the threshold level by modeling chemicals that 
currently carry NIOSH skin notations. To pro-
vide a consistent basis for comparing model-
ing results, the following exposure parameters 
were treated as constants during the investiga-
tion (with assumptions made for reasonably 
representing the conditions of skin exposures): 
(1) concentration of the chemical on the skin 
surface, (2) surface area of exposed skin, and 
(3) exposure duration. If exposure conditions 
are not known, these parameters will remain 
as constants when the algorithm is used to es-
timate the SI ratio for assigning the SYS nota-
tion. Note that in actual workplace situations, 
these exposure parameters are likely to vary 
from the values assumed here, depending on 
the chemicals and the industrial processes or 
tasks involved. Before using the predictive al-
gorithm to assess the risk of a given chemical 
exposure during a specific task, an exposure 
assessment should be conducted to sufficient-
ly characterize all relevant information. The 
mathematical model described here may be 
improved and updated as more dermal absorp-
tion data become available and other facets of 
dermal penetration are incorporated into the 
model. 
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C.1 Using pH and acid/alkali 
reserve to identify skin 
corrosives
In A Sequential Testing Strategy for Dermal Ir-
ritation and Corrosion, the supplement to the 
OECD Guideline for Testing of Chemicals 404 
[OECD 2002], the OECD recommends using 
a weight-of-evidence analysis on existing rel-
evant data before undertaking in vivo testing 
to evaluate skin corrosion. Relevant data en-
compass data generated from methods alterna-
tive to biologic testing, including “evidence of 
corrosivity/irritation of one or more structur-
ally related substances or mixtures of such sub-
stance” and “data demonstrating strong acid-
ity or alkalinity of the substance.” The OECD 
Guideline also specifies that the acid/alkali re-
serve (or buffering capacity) be considered if a 
chemical is recognized as a skin corrosive on 
the basis of its extreme pH. Using pH and acid/
alkali reserve to identify potential skin corro-
sives is in accordance with the approach adopt-
ed in the GHS [UNECE 2005]. In this system, 
the appropriate evaluation of extreme pH val-
ues (≤ 2.0 or ≥ 11.5) (including acid/alkaline 
reserve capacity) is accepted as a decision logic 
for recognizing corrosive agents.
When a chemical is evaluated for potential 
skin corrosivity based on pH and buffering 
capacity, the substance is to be recognized as 
corrosive following the outlined predictive 
models [Worth et al. 1998]:
 • pH ≤ 2.0 or ≥ 11.5
 • pH − (acid reserve ÷ 6) ≤ 1 or
 • pH + (alkali reserve ÷ 12) ≥ 14.5
where the acid reserve of a substance is the 
amount in grams of sodium hydroxide re-
quired to bring 100 g of a test substance (in 
a 10% solution or suspension) to a pH of 4, 
and the alkali reserve is the amount in grams 
of sulfuric acid required to bring 100 g of a 
test substance to a pH of 10. (See Young et al. 
[1988] for details about the generation and use 
of acid/alkali reserve measurements.)
C.2 Using structural alerts 
implemented in the 
DEREK™ expert system to 
identify sensitizers
The knowledge-based DEREK™ expert system 
contains algorithms to predict the toxicity of 
chemical mixtures based on a series of struc-
ture-activity rules (also known as structural 
rules or structural alerts). These rules describe 
the substructures of chemical molecules po-
tentially responsible for adverse health effects 
[Ridings et al. 1996]. As part of the DEREK™ 
expert system architecture, a rule base for 
APPENDIX C • Identifying skin corrosives and 
sensitizers using physicochemical properties 
and structure activity relationship-based 
analysis 
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identifying potential contact allergens was de-
rived using results of the guinea pig maximiza-
tion test conducted for 294 substances classi-
fied as strong or moderate sensitizers [Barratt 
et al. 1994]. The rule base initially consisted 
of 40 structural rules and has been continu-
ously updated since its inception. Workshop 
19 of the European Centre for the Validation 
of Alternative Methods discussed the DEREK™ 
skin sensitization rule base as an alternative to 
skin sensitization testing. The Workshop rec-
ommended that QSAR predictions and expert 
systems serve as screens for identifying posi-
tive substances [de Silva et al. 1996].
Zinke et al. [2002] assessed the effectiveness of 
these structural alerts for identifying the skin-
sensitizing properties of chemicals. The re-
searchers evaluated the 40 originally published 
structural alerts against a database developed 
in the German Federal Institute for Health Pro-
tection of Consumers and Veterinary Medicine 
(BgVV). The BgVV database contained data 
submitted under its procedure for notifica-
tion about new chemicals within the European 
Union and data on the skin-sensitization po-
tentials of 1,039 substances [Zinke et al. 2002]. 
Zinke et al. [2002] reported that among the 
structural alerts examined, eight could be used 
to identify contact allergens without further 
refinement. These alerts are for acid halides, 
acid anhydrides, isocyanates, isothiocyanates, 
β-lactams, aldehydes, epoxides, and quaterna-
ry ammonium cation.
These structural alerts will be used to evaluate 
substances for their potential as skin sensitiz-
ers when no human or biologic testing data 
are available. As the DEREK™ structural rules 
continue to be refined, it is anticipated that ad-
ditional alerts will be validated and available to 
identify hazards and facilitate the assignment 
of SK: SEN notations.
References
Barratt MD, Basketter DA, Chamberlain 
M, Admans GD, Langowski JJ [1994]. An 
expert system rulebase for identifying contact 
allergens. Toxicol in Vitro 8(5):1053–1060.
de Silva O, Basketter DA, Barratt MD, Corsini 
E, Cronin MTD, Das PK, Degwert J, Enk A, 
Garrigue JL, Hauser C, Kimber I, Lepoittevin J-P, 
Peguet J, Ponec M [1996]. Alternative methods 
for skin sensitization testing. The report and 
recommendations of ECVAM Workshop 19. 
Altern Lab Animals 24:683–705.
OECD [2002]. OECD guideline for the testing 
of chemicals. Acute dermal irritation/corrosion. 
404. Adopted: 24 April 2002. Paris, France: 
Organization for Economic Cooperation and 
Development.
Ridings JE, Barratt MD, Cary R, Earnshaw CG, 
Eggington CE, Ellis MK, Judson PN, Langowski 
JJ, Marchant CA, Payne MP, Watson WP, Yih 
TD [1996]. Computer prediction of possible 
toxic action from chemical structure: an update 
on the DEREK™ system. Toxicol 106:267–279.
UNECE [2005]. Globally harmonized system 
of classification and labeling of chemicals 
(GHS). ST/SG/AC.10/30. New York, USA, and 
Geneva, Switzerland: United Nations Economic 
Commission for Europe. 
Worth AP, Fentem JH, Balls M, Botham PA, 
Curren RD, Earl LK, Esdaile DJ, Liebsch M 
[1998]. An evaluation of the proposed OECD 
testing strategy for skin corrosion. Altern Lab 
Animals 26:709–720. 
Young JR, How MJ, Walker AP, Worth WMH 
[1988]. Classification as corrosive or irritant to 
skin of preparations containing acid or alkaline 
substances, without testing on animals. Toxic 
in Vitro 2(1):19–26.
33NIOSH CIB 61 • Skin Notations
Zinke S, Gerner I, Schlede E [2002]. Evaluation 
of a rule base for identifying contact allergens by 
using a regulatory database: comparison of data 
on chemicals notified in the European Union 
with “structural alerts” used in the DEREK™ 
expert system. Altern Lab Animals 30:285–298.

35NIOSH CIB 61 • Skin Notations
D.1 Selecting chemicals for 
evaluation 
Chemicals can be identified and selected for eval-
uation based on the strategic framework outlined 
in this CIB through three primary pathways: 
1. When recognized as existing occupation-
al hazards or associated with potential 
emerging issues
2. When nominated by interested parties, 
including NIOSH stakeholders, other 
governmental agencies, and the public
3. When listed in the NIOSH Pocket Guide 
to Chemical Hazards. 
Chemicals identified as emerging issues, exist-
ing as occupational hazards, or nominated for 
evaluation will be assessed by NIOSH based on 
the availability of quality data that clearly out-
line the hazards posed by the candidate chemi-
cal. For chemicals listed within the NIOSH 
Pocket Guide to Chemical Hazards, a hierarchal 
ranking scheme has been developed to priori-
tize candidate chemicals (see Appendix D.2). 
D.2 Selecting and prioritizing 
candidate chemicals found 
within the NIOSH Pocket 
Guide to Chemical Hazards
The NIOSH Pocket Guide to Chemical Hazards 
lists 142 chemicals assigned the skin notation 
[skin], which indicates the potential for dermal 
absorption. These substances have been selected 
to be the first evaluated through the strategic 
framework outlined in this CIB. As part of this 
process, a hierarchal ranking scheme that applies 
a binominal hazard-ranking approach has been 
developed to aid in the ranking of the many can-
didate chemicals. Parameters addressed within 
the hierarchal scheme of prioritizing the candi-
date chemicals include the following: 
 • Potential health hazards
 • Potential for occupational exposure
 • Annual production volume
 • OELs recommended by both govern-
mental and nongovernmental organiza-
tions.
An array of information resources containing 
data related to the outlined parameters were 
assessed to aid in ranking the chemicals to be 
classified according to the new strategy. The 
following information resources were applied 
within this scheme:
ATSDR Toxicological Profiles 
(ToxProfiles)
www.atsdr.cdc.gov/toxpro2.html
European Inventory of Existing Com-
mercial chemical Substances (EINICS) 
http://ecb.jrc.it/esis/index.php?PGM=ein
National Occupational Exposure Survey 
(NOES)
www.cdc.gov/noes/
APPENDIX D • Selecting and Prioritizing 
Candidate Chemicals
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NIOSHTIC-2 
www2a.cdc.gov/nioshtic-2/advsearch2.asp
NIOSH Immediately Dangerous to Life 
and Health (IDLH) Values 
www.cdc.gov/niosh/idlh/idlh-1.html
NIOSH International Chemical Safety 
Card (ICSC)
www.cdc.gov/niosh/ipcs/nicstart.html
NIOSH Pocket Guide to Chemical 
Hazards
www.cdc.gov/niosh/npg/ 
NIOSH Registry of Toxic Effects of 
Chemical Substances (RTECS) 
www.cdc.gov/niosh/rtecs/rteccas1.html
NIOSH Recommendations for 
Occupational Safety and Health, 
Compendium of Policy Documents and 
Statements
www.cdc.gov/niosh/pubs/all_date_desc_
nopubnumbers.html
NIOSH Skin Exposures and Effects 
Topic Page
www.cdc.gov/niosh/topics/skin/
OSHA Permissible Exposure Limits
www.osha.gov/SLTC/pel/
U.S. EPA High Production Volume 
Information System (HPV)
www.epa.gov/hpvis/
The 142 chemicals previously assigned the 
notation [skin] by NIOSH were systemati-
cally assigned a score from 0–7 to determine 
which substances posed the greatest potential 
occupational health hazard based on the pa-
rameters outlined in Table D.1. The scores for 
15 chemicals are illustrated within Table D.2. 
The hierarchal ranking scheme may be modi-
fied in the future to aid NIOSH in prioritizing 
(1) chemicals listed within the NIOSH Pocket 
Guide to Chemical Hazards that do not have 
the notation [skin] and (2) chemicals nomi-
nated for evaluation from stakeholders, gov-
ernmental agencies, and public interest groups.
Table D.1. Definition scoring of parameters applied with hierarchal ranking scheme
Parameter Definition and scoring
OEL potency If OEL is < 1 mg/m3, assign score of 1; 
if not, assign score of 0.
Carcinogen If identified as a carcinogen, assign score of 0.5;  
if not, assign score of 0.
Reproductive/development 
toxicant
If identified as a reproductive or development toxicant, assign score of 0.5;  
if not, assign score of 0.
Irritant/corrosive If identified as a corrosive, assign score of 1;  
if identified as an irritant only, assign score of 0.5;  
if identified as neither, assign score of 0.
(Continued)
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Table D.1 (Continued). Definition scoring of parameters applied  
with hierarchal ranking scheme
Parameter Definition and scoring
Sensitizer If identified as a sensitizer, assign score of 1;  
if not, assign score of 0.
HPV chemical If identified as a HPV chemical, assign score of 1;  
if not, assign score of 0.
Exposure potential If identified within NOES data as having potential to expose > 75,000 workers, as-
sign score of 1;  
if not, assign score of 0.
RTECS or  
risk phrases (R-phrases) 
If identified within RTECS as either extremely or highly hazardous or within the 
R-phrases as either highly toxic or toxic, assign score of 1,  
if not assign 0. 
Table D.2. Example of the application of the hierarchal ranking scheme  
ranking of 15 candidate chemicals 
Chemical
CAS 
no.
OEL*
Potency CAN† R/DT‡
IRR/
COR§ SEN¶ HPV**
Expo-
sure po-
tential
Skin 
 hazard††
Overall
score
Epichlorohydrin 106–89–8 0 0.5 0.5 1 1 1 1 1 6
Acrylonitrile 107–13–1 0 0.5 0.5 0.5 1 1 1 1 5.5
Dichlorvos 62–73–7 1 0.5 0.5 0.5 1 1 0 1 5.5
Hydrazine 302–01–2 1 0.5 0.5 1 1 0 0 1 5
p-Phenylene 
diamine
106–50–3 1 0.5 0 0.5 1 1 0 1 5
Acrylamide 79–06–1 1 0.5 0.5 0.5 1 1 0 0 4.5
Phenol 108–95–2 0 0 0.5 1 0 1 1 1 4.5
Acrylic Acid 79–10–7 0 0 0 1 1 1 1 0 4
(Continued)
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Table D.2 (Continued). Example of the application of the hierarchal ranking 
scheme ranking of 15 candidate chemicals 
Chemical
CAS 
no.
OEL*
potency CAN† R/DT‡
IRR/
COR§ SEN¶ HPV**
Expo-
sure po-
tential
Skin 
 hazard††
Overall
score
Diethylenetri-
amine
111–40–0 0 0 0 1 1 1 1 0 4
Heptachlor 76–44–8 1 0.5 0.5 0 0 1 0 1 4
o-Cresol 95–48–7 1 0 0 1 0 1 0 1 4
Phenylhydrazine 100–63–0 1 0.5 0 0.5 1 0 0 1 4
1,3-Dichloropro-
pene
542–75–6 0 0.5 0.5 0.5 1 1 0 0 3.5
2-Ethoxyethanol 110–80–5 0 0 0.5 0 0 1 1 1 3.5
Aniline 62–53–3 0 0.5 0 0 1 1 0 1 3.5
*OEL = Occupational Exposure Limits
†CAN = Carcinogen
‡R/DT = Reproductive and Development Toxicant
§IRR/COR = Irritant/Corrosive
¶SEN = sensitizer
**HPV = High Production Volume Chemical
††Skin Hazard = Based on information provided by RTECS and EU risk phrases
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E.1 Literature search
The literature search strategy has been de-
veloped to identify critical scientific data on 
(1) physical and chemical properties of candi-
date substances, (2) human health effects as-
sociated with exposures to substances, (3) re-
ported results of in vivo and in vitro toxicity 
testing, and (4) estimates of chemical toxico-
kinetics and toxicity based on computational 
techniques. The primary sources of informa-
tion reviewed during the literature search are 
peer-reviewed journals, domestic and interna-
tional governmental agencies reports, reference 
books, private industry reports, and scientific 
evaluations from public interest organizations. 
The literature search strategy includes search 
terms within electronic databases to ensure the 
identification of relevant scientific data. 
E.1.1 Primary sources 
E.1.1.1 Electronic databases 
The following databases are searched:
European Inventory of Existing 
 Commercial chemical Substances 
(EINICS) 
http://ecb.jrc.it/esis/index.php?PGM=ein
EMBASE
www.embase.com/
 Extension Toxicology Network 
( EXTOXNET) 
http://extoxnet.orst.edu/pips/ghindex.html
Haz-Map: Occupational Exposure to 
 Hazardous Agents (Haz-Map)
www.nlm.nih.gov/pubs/factsheets/
hazmap.html
Hazardous Substances Data Bank (HSDB)
http://toxnet.nlm.nih.gov/cgi-bin/sis/
htmlgen?HSDB
Integrated Risk Information System (IRIS)
http://toxnet.nlm.nih.gov/cgi-bin/sis/
htmlgen?IRIS
International Toxicity Estimates for Risk 
(ITER)
http://toxnet.nlm.nih.gov/cgi-bin/sis/
htmlgen?iter
NIOSH Registry of Toxic Effects of 
 Chemical Substances (RTECS) 
www.cdc.gov/niosh/rtecs/
NIOSHTIC-2 
www2a.cdc.gov/nioshtic-2/advsearch2.asp
National Toxicology Program Report on 
Carcinogens (NTP)
http://ehis.niehs.nih.gov/roc/
OSH References Collection 
http://ccinfoweb.ccohs.ca/bibliographic/
search.html
PubMed
www.ncbi.nlm.nih.gov/sites/
entrez?db=pubmed
Toxicology Literature Online 
(TOXLINE) database from the U.S. 
National Library of Medicine’s TOXNET 
APPENDIX E • Guidelines and Criteria for the 
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http://toxnet.nlm.nih.gov/cgi-bin/sis/
htmlgen?TOXLINE
U.S. Environmental Protection Agency 
(U.S. EPA) Substance Registry Services
www.epa.gov/srs/
Web of Science
http://thomsonreuters.com/products_ 
services/scientific/Web_of_Science
E.1.1.2 Published books, technical 
documents, and Web sites
The following published books, technical docu-
ments, and Web sites represent common sourc-
es used during the derivation of the new NIOSH 
skin notations:
Agency for Toxic Substances and 
Disease Registry (ATSDR) Public Health 
Statements (PHS) Web site
www.atsdr.cdc.gov/phshome.html
ATSDR TOXFAQS Web site
www.atsdr.cdc.gov/toxfaq.html
ATSDR Toxicological Profiles Web site
www.atsdr.cdc.gov/toxpro2.html 
American Conference of Governmental 
Industrial Hygienists (ACGIH)
Documentation of the Threshold Limit 
Values (TLV) for Chemical Substances 
and Physical Agents
American Industrial Hygiene Association 
(AIHA) Workplace Environmental 
Exposure Levels Guide (WEEL) Web site
www.aiha.org/webapps/taxonomy/
documentrepository/erpgweels/7d11ed78-
37da-4ce1-99f2-763603376151.pdf
California Environmental Protection 
Agency (CalEPA) Health Reports Web site 
www.calepa.ca.gov/Publications/
Cassarett and Doull’s Toxicology: The 
Basic Science of Poisons
European Commission Risk Assessment 
Reports Web site
http://ec.europa.eu/health/ph_risk/risk_
en.htm
Hamilton and Hardy’s Industrial 
Toxicology
Health and Safety Executive (HSE) 
Publications Web site
www.hse.gov.uk/pubns/index.htm
International Agency for Research on 
Cancer (IARC) Monographs on the 
Evaluation of Carcinogenic Risks to 
Humans Web site
http://monographs.iarc.fr
International Programme on Chemical 
Safety (IPCS) Web site 
www.inchem.org/
Merck Index
National Industrial Chemicals 
Notification and Assessment Scheme 
(NICNAS) Scientific Reports Web site
www.nicnas.gov.au/
NIOSH International Chemical Safety 
Cards (ICSC)
www.cdc.gov/niosh/ipcs/nicstart.html
NIOSH Pocket Guide to Chemical 
Hazards
www.cdc.gov/niosh/npg/
NIOSH Publications Web site
www.cdc.gov/niosh/pubs/all_date_desc_
nopubnumbers.html
NIOSH Registry of Toxic Effects of 
Chemical Substances (RTECS) 
www.cdc.gov/niosh/rtecs/rteccas1.html
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New Jersey Right to Know Hazardous 
Substances Fact Sheets Web site web.
doh.state.nj.us/rtkhsfs/indexfs.aspx
Occupational and Exposure Exposures 
of the Skin to Chemicals (OEESC) 
Conference Abstracts 
http://inside.mines.edu/outreach/cont_ed/
oeesc/
www.cdc.gov/niosh/topics/skin/OEESC2/
index.html
www.oeesc2009.pwp.blueyonder.co.uk/
OEESC/Abstracts.html
Patty’s Industrial Hygiene and 
Toxicology
Proctor and Hughes’ Chemical Hazards 
of the Workplace
OSHA Publications Web site 
www.osha.gov/
U.S. EPA Web site
www.epa.gov/
U.S. National Technical Information 
Service (NTIS) Web site 
www.ntis.gov/
U.S. National Toxicology Program 
(NTP) Study Reports 
http://ntp.niehs.nih.gov/ntpweb/index.
cfm?objectid=7DA86165-BDB5-82F8-
F7E4FB36737253D5
E.1.2 Search terms
Literature searches are conducted by NIOSH 
technical informational specialist for a candi-
date chemical based on the substance’s Chemical 
Abstract Services Number (CAS No.), chemical 
nomenclature, common names, and synonyms. 
Additional terminology used during the litera-
ture search can be located in Table E.1.
E.2 Evaluation of data
A qualitative classification scheme has been 
developed to aid in the evaluation of data sets 
identified through the literature search. This 
Table E.1. Terminology applied during the search for critical scientific data on  
each candidate chemical substance
Acne* Epicutaneous* Keratoacanthoma QSAR 
Allerg* Epiderm* Keratoderma QSPR
Apocrine Episkin Keratosis Radiodermatitis 
Argyria Erythema Leukoderma Rash*
Atopic Exanthema Lichenoid Redness
Blister* Exfoliat* Miliaria Sebaceous 
Burn Fingernail* Mucocutaneous Sensitizer
Callosity Follicle* Neurodermat* Skin 
Cancer* Gangren* Onychomyco* Skin Diseases
Corrosion Granuloma Pain Skin Irritancy Tests
Crositex* Hirsut* Pallor Skin Physiology 
(Continued)
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scheme relies on a case-by-case analysis of the 
assembled data using a weight-of-evidence ap-
proach. Other general considerations used to 
evaluate the assembled data include:
 • How many studies were identified? 
 • Were the identified studies peer- reviewed?
 • Were the identified data generated using 
standardized protocols (e.g., guidelines 
established by OECD, European Centre 
for the Validation of Alternative Meth-
ods, U.S. EPA, or NTP?
 • Were the exposure conditions and the 
studies’ reported findings described in 
detail? 
 • Should any other available information 
be considered?
Based on the results of this qualitative classi-
fication scheme, the data sets are classified as 
sufficient, limited, or insufficient. These rank-
ings are intended to aid in assessing the over-
all quality and completeness of the assembled 
data sets. Data sets classified as sufficient are 
those that include human and/or animal tox-
icity studies conducted according to stan-
dardized protocols and that provide in-depth 
descriptions of the exposure conditions and 
study findings. Data sets classified as limited 
via the qualitative ranking scheme contain ei-
ther human and/or animal studies conducted 
by nonstandardized protocols or contain in-
complete descriptions of the exposure condi-
tions and study findings. Data sets classified 
as insufficient include studies that primarily 
either did not apply standard protocols or did 
not provide an in-depth description of the ex-
posure conditions or study findings. Data sets 
that receive the insufficient ranking will not be 
used as the basis for the NIOSH skin notation.
Table E.1 (Continued). Terminology applied during the search for critical 
scientific data on each candidate chemical substance
Cutaneous Hyperhidrosis* Panniculitis Skin Tests 
Cutis Hyperpigment* Papulosquamous Stratum Corneum 
Cyst Hypertricho* Paronychia Structure Activity Relationship 
Cystic Hypopigment* Patch Test* Sunburn 
Cysts Hypotricho* Photoallerg Sweat 
Skin* Inflammation Photosensitiv* Ulcer*
Dermatitis Immune Phototoxic* Urticaria 
Dermato* Intertrigo Porphyria* Vacciniforme 
Dermis Intraskin* Prurigo Vesiculobullous 
Eccrine Irritat* Prurit* Xeroderma 
Ectoderm* Jaundice Psoriasis 
Eczema* Keloid Purpura 
*Indicates truncated terms used within the literature search
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This appendix documents the assignment of 
skin notations based on the scientific criteria 
outlined in this document. This profile con-
tains a proposed skin notation assignment 
and supporting documentation for phenol 
(CAS No.108–95–2). It should be noted that 
the presented information is intended to serve 
only as in illustration of the strategy outlined 
in this CIB to assess the hazards of skin con-
tact with phenol. The proposed skin notation 
assignment should not be construed as official 
NIOSH policy.
Each section of this appendix contains a brief 
summary highlighting the rationale for assign-
ing or not assigning the various skin notations. 
References that are bold indicate primary studies. 
F.1 Chemical background 
information and 
introduction
Skin Notation for Phenol:  
SK: SYS-DIR (COR)
This documentation for skin notation assign-
ments is limited to an assessment of the po-
tential health effects following skin exposure 
or the potential for direct skin injuries from 
phenol. A literature search was conducted 
through November 2006 to identify potential 
health effects information on phenol toxicoki-
netics, acute, repeat-dose, and chronic toxicity, 
carcinogenicity, and biologic-system/function-
specific effects (including reproductive and 
developmental effects and immunotoxicity), 
irritation, and sensitization. Information was 
considered from studies in humans, animals, or 
appropriate modeling systems that are relevant 
to skin exposure to phenol. This toxicological 
review is intended to provide brief documen-
tation of the rationale in support of the SK as-
signments for this chemical, which were based 
on the logic outlined in CIB #61: A Strategy for 
Assigning New NIOSH Skin Notations [NIOSH 
2009]. Table F.1 provides a summary of the as-
signed skin notations for phenol, and data sup-
porting these notations are summarized below. 
 • This section outlines (1) background in-
formation on phenol, (2) briefly discusses 
the application of the literature search 
(Appendix E.1), and (3) summarizes the 
skin notations assigned to phenol. Table 
F.1 includes the identification of critical 
effects associated with each assigned skin 
notation, and a description of the quality 
APPENDIX F • Example of Assigning New NIOSH 
Skin Notations and Format of the Skin Notation 
Profile 
Skin Notation Profile for Phenol  
(CAS No. 108–95–2)
Synonyms: Structure:
Carbolic acid, 
monohydroxybenzene, 
hydroxybenzene, 
benzenol, phenylic 
acid, phenyl hydroxide, 
benzophenol, phenyl 
hydrate, phenylic alcohol, 
monophenol, phenic 
acid, oxybenzene
HO
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and type of data used to determine the 
skin notation assignment for phenol (Ap-
pendix E.2). 
F.2 Systemic toxicity from skin 
exposure
Toxicokinetic studies of phenol have been 
identified. Dermal absorption of phenol by 
human subjects has been reported to range 
from 4%–23% of the applied dose, depend-
ing on the period of exposure and the con-
centration of phenol [Feldman and Maibach 
1970; Piotrowski 1971; Roberts et al. 1977; 
 Baranowska-Dutkiewicz 1981]. In male vol-
unteers, the rate of absorption of an aqueous 
phenol solution (2.5, 5.0, or 10.0 g/L from a 
2 mL reservoir) applied directly to the forearm 
(15.6 cm2) was found to be concentration-de-
pendent, with the rate ranging from 0.079 mg/
cm2/hr at the low concentration to 0.301 mg/
cm2/hr at the high concentration [Baranowska- 
Dutkiewicz 1981]. In this study, the total 
amount of phenol absorbed—but not the rate 
of absorption—at the low concentration in-
creased with time, with 12.6% and 22.7% of the 
applied dose absorbed in 30 and 60 minutes, 
respectively. Feldman and Maibach [1970] 
reported the degree of dermal absorption as 
4.4% of the administered dose following a sin-
gle topical application of 4 µg/cm2 phenol on 
13 cm2 of the unprotected ventral forearm of 
human adults. Phenol vapors are also reported 
to readily penetrate the skin with absorption 
efficiency equal to that of inhalation, thus con-
tributing to the total skin exposure [Piotrowski 
1971]. In a whole-body skin exposure study 
in which unclothed and lightly clothed volun-
teers were exposed to phenol vapors at con-
centrations from 1.3–6.5 ppm for 6 hours, but 
were breathing clean air by mask, reported that 
absorption increased proportionately with air 
concentration [Piotrowski 1971]. These stud-
ies generally demonstrated that phenol can be 
absorbed through the human skin.
The potential of phenol to be absorbed through 
the skin has also been evaluated in laboratory 
animals. Hughes and Hall [1997] reported a 
120-hour cumulative dermal absorption of 
66%–80% in young rats (29-day-old female rat). 
In an earlier study, the same authors [Hughes 
and Hall 1995] reported that approximately 
85% of the dose of phenol was absorbed in 72 
hours in 90-day-old female rats after dermal 
administration of phenol. In vitro studies using 
Table F.1. Skin notation for phenol
Supporting data for phenol skin notation
Skin notations Critical effects Available data
SK: SYS Central nervous system ef-
fects, Respiratory depres-
sion, cardiac arrest, body 
weight changes, decreased 
survival.
Sufficient human and animal data 
SK: DIR (COR) Skin corrosivity Sufficient human and animal data
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laboratory animal tissues also indicate that phe-
nol is absorbed through the skin. For example, 
in an in vitro system using dermatomed rat 
skin, Hughes et al. [1993] reported a 72-hour 
dermal absorption of phenol of 95% of the ap-
plied dose. Brooks and Riviere [1996] consid-
ered a recent study that evaluated dermal ab-
sorption of phenol in acetone and water under 
nonoccluded and occluded applications using 
isolated perfused porcine skin. The authors re-
ported absorption, penetration into tissues, and 
total recoveries of phenol to be greater under 
occluded than nonoccluded conditions and that 
for each solvent, the absorption percentage was 
higher with the low-dose (4 μg/cm2) compared 
to the high-dose (40 μg/cm2), suggesting satu-
ration of absorption or other nonlinear kinetics 
under some conditions of exposure. Depend-
ing on the solvent and dose, Brooks and Riviere 
[1996] reported that dermal absorption ranged 
from 9.24%–14.62% under occluded conditions 
at the low dose and 2.90%–5.45% under non-
occluded condition. In vitro permeability coef-
ficients for phenol were found to increase with 
increasing concentration of aqueous phenol 
applied to mouse skin [Behl et al. 1983], with 
a 12-fold increase in mean coefficient (0.007–
0.085  cm / hour) resulting from doubling the 
concentration from 20 g/L to 40 g/L, and a value 
of 0.169 cm/hr noted when 60 g/L was applied 
[Behl et al. 1983]. The authors concluded that 
phenol concentrations exceeding 20 g/L may 
destroy a diffusion barrier normally provided 
by the intact stratum corneum, permitting in-
creased dermal absorption. Results from animal 
studies in vivo and studies using animal skin in 
vitro also demonstrated that phenol is absorbed 
through the skin of animals. The potential of 
phenol to pose a skin absorption hazard was 
also evaluated using the NIOSH [2009] predic-
tive algorithm for estimating and evaluating the 
health hazards of skin exposure to substances. 
Based on this algorithm, the ratio of the skin 
dose to the inhalation dose (SI ratio) of 11 was 
calculated for phenol. This ratio is significantly 
higher than the SI ratio of greater than or equal 
to 0.1 indicating that skin absorption may sub-
stantially contribute to the overall body burden 
of a chemical. For this reason, phenol is consid-
ered to be absorbed through the skin following 
dermal contact. The result from the predictive 
algorithm supports the results from human and 
animal studies in vivo and from in vitro studies. 
 • Application of Appendix A.1.1: Dermal 
absorption. The results of studies using 
human subjects have reported that dermal 
absorption of phenol range from 4%–23% 
of the applied dose. The studies indicate 
that phenol may be readily absorbed in liq-
uid or vapor forms. Animal studies using 
different protocols report dermal absorp-
tion range from 9%–85% of the applied 
dose in multiple species. For this reason, 
phenol is identified as having a high po-
tential to be absorbed following contact 
with the skin in liquid and vapor forms.
Several case reports of humans dermally ex-
posed to varying doses of phenol have been 
identified [Griffiths 1973; Soares and Tift 1982; 
Lewin and Cleary 1982; Turtle and Dolan 
1922; Foxall et al. 1989]. In these reports, ac-
cidental exposure of phenol to intact skin or 
intentional (therapeutic) application of phe-
nol to the skin has resulted in fatalities (from, 
e.g., respiratory depression and cardiac arrest), 
but the doses were not known with any accu-
racy, precluding estimation of a lethal dermal 
dose for humans. In animals, the dermal LD50 
values (the dose resulting in 50% mortality in 
the exposed animals) range from 0.5 mL/kg 
body weight to 0.68 mL/kg (corresponding to 
669–1,500  mL / kg body weight) [Conning and 
Hayes 1970; Brown et al. 1975] in rats under 
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both occlusive and nonocclusive conditions 
and 1400 mg/kg in rabbits [Vernot et al. 1977]. 
The Conning and Hayes [1970] study reported 
severe muscular tremors, twitching, general-
ized convulsions with loss of consciousness, 
and prostration occurring within 10 minutes 
of skin exposure to phenol in water; subjects 
developed severe hemoglobinuria from 45–90 
minutes. Brown et al. [1975] reported hema-
turia and convulsions as clinical signs of phe-
nol toxicity. Because the reported acute dermal 
LD50 values for the rat and rabbit are both low-
er than the critical dermal LD50 value of 2  g / kg 
body weight that identifies substances with the 
potential for acute dermal toxicity [NIOSH 
2009], phenol is considered systemically toxic 
by the acute dermal route. 
 • Application of Appendix A.1.2: Evalu-
ation of acute toxicity of exposures 
of the skin. The reported LD50 of 414–
1400  mg / kg body weight did not exceed 
the critical cutoff value of 2000 mg/kg 
body weight. For this reason, phenol is as-
signed the SYS notation.
Quantitative information on doses that cause 
systemic effects during repeated occupational 
exposures is lacking. However, doses chronic 
to humans (unspecified) may result in neuro-
logic damage [Merliss 1972]. A number of re-
peat-dose animal studies have been identified 
in which show systemic effects following skin 
exposure to phenol. Deichmann et al. [1950] 
exposed the tail of rabbits to aqueous phenol 
solutions of 1.18%–7.12% in water (reported 
as 64–380  mg / kg by the International Program 
for Chemical Safety IPCS [1994]) for 5 hr/day, 
5 days/week, for a total of 18 days. Dose-related 
systemic effects (tremors, death) were observed 
at 130 mg phenol/kg and above. Identified in 
this study were a NOAEL of 64 mg/kg-day and 
a LOAEL of 130 mg/kg-day to protect against 
occasional mild tremors and skin irritation. 
Boutwell and Bosch [1959] conducted a study 
in mice involving skin painting of 25 microli-
ter (μL) of a 5% [1.25 milligram (mg)] phenol 
or a 10% (2.5 mg phenol) in benzene per ap-
plication, twice weekly for 52 weeks. The high 
dose (10%) caused decreased body weight 
(average body weight at the 20th week for the 
group dosed 10% was 35.0 g compared with 
38.9 g at the 5% level of phenol) and decreased 
survival (24/30 mice survived at the end of 52 
weeks compared with 30/30 at the 5% level of 
phenol at the 20th week). The resulting doses 
were reported as 41.7 and 83.3 mg/kg/treatment 
[ATSDR 2006]. The potential skin and systemic 
effects of the benzene solvent were not inves-
tigated in this study; however, the effect levels 
of 18 mg/kg-day from the Boutwell and Bosch 
study [1959] and 130  mg / kg-day identified in 
the shorter-duration study by Deichmann et 
al. [1950] together indicate the potential for ef-
fects at doses significantly lower than the critical 
dermal NOAEL value of 1000 mg/kg for repeat-
dose toxicity. This NOAEL identifies substances 
with the potential for subchronic dermal toxic-
ity [NIOSH 2009]. Therefore, phenol is consid-
ered to be systemically toxic following repeated 
dermal exposure. 
 • Application of Appendix A.1.3: Evalu-
ation of repeat-dose toxicity. The doses 
reported in the reviewed studies ranging 
from 18–130 mg/kg-day did not exceed 
the cutoff value of 1000 mg/kg-day body 
weight. For this reason, phenol would be 
assigned the SYS notation.
No standard toxicity or specialty studies evaluat-
ing biologic-system/function-specific effects (in-
cluding reproductive and developmental effects 
and immunotoxicity) following skin exposure to 
phenol were identified in humans or animals. 
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 • Application of Appendix A.1.7: Toxic 
effects of exposures of the skin on or-
gan systems or biologic functions. No 
evidence was identified that evaluated the 
effects of phenol on organ systems or bio-
logic functions. The SYS notation would 
not be assigned to phenol based on the 
criteria outlined in this section.
Although a literature search identified no epide-
miologic studies that allowed for evaluation of 
the carcinogenic potential of phenol, a limited 
number of studies in animals involving repeated 
application of phenol in benzene [Boutwell and 
Bosch 1959] or in acetone [Salaman and Glen-
denning 1957; Wynder and Hoffman 1961] in 
two-stage carcinogenicity protocols in mice in-
dicated that phenol has promoting activity. Stud-
ies conducted by Boutwell and Bosch [1959] in 
several strains of mice also suggested that phe-
nol in benzene or dioxane is a tumor promoter 
and possibly a complete carcinogen (i.e., having 
both promoting and initiating activity). In the 
latter study, phenol elicited skin tumors in mice 
even in the absence of a tumor-initiating agent 
(i.e., 9,10-dimethyl-1,2-benzanthracene). These 
studies are inadequate for the evaluation of the 
carcinogenic potential of phenol because of the 
following:
 • The short duration of exposures applied in 
the studies [32 weeks (Salaman and Glen-
denning 1957), 12 months or 52 weeks 
(Salaman and Glendenning 1957; Bout-
well and Bosch 1959)]
 • The lack of appropriate controls [Salaman 
and Glendenning 1957], and/or
 • The use of vehicles (dioxane, benzene) that 
are skin irritants and/or defatting agents 
Other agencies or organizations have also eval-
uated the potential of phenol to be a carcinogen 
following exposure pathways alternative to the 
skin. NIOSH [2006] does not classify phenol as 
a potential occupational carcinogen. The U.S. 
EPA states that the data regarding the carcino-
genicity of phenol through the ingestion, in-
halation, and dermal routes are inadequate for 
an assessment of human carcinogenic potential 
[U.S. EPA 2002]. The American Conference 
of Governmental Industrial Hygienists (AC-
GIH) has assigned an A4 (not classifiable as a 
human carcinogen) notation to phenol [AC-
GIH 2001]. IARC has classified phenol as not 
classifiable as to its carcinogenicity to humans 
(Group 3) [IARC 2007].
 • Application of Appendix A.1.6: Evalu-
ation of carcinogenicity of phenol. No 
evidence was identified that would sup-
port identifying phenol as a carcinogen 
or the subsequent assignment of the SYS 
notation.
Identified human [Feldman and Maibach 1970; 
Piotrowski 1971; Baranowska- Dutkiewicz 
1981] and animal [Behl et al. 1983; Hughes 
and Hall 1995; Brooks and Riviere 1996] toxi-
cokinetic data, acute dermal toxicity studies 
[Conning and Hayes 1970; Brown et al. 1975; 
Vernot et al. 1977], and repeat-dose studies 
[Deichmann et al. 1950; Boutwell and Bosch 
1959] are sufficient to demonstrate the potential 
for phenol to be dermally absorbed and system-
ically toxic. Systemic toxicity includes effects 
on the central nervous system, body weight 
changes, and decreased survival. Therefore, this 
assessment concludes that  sufficient human and 
animal data exist to assign the SK: SYS notation 
for phenol.
F.3 Direct effect(s) on the skin
The available information indicates that phe-
nol is corrosive to the skin. For example, skin 
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exposure to liquid phenol or concentrated phe-
nol vapor caused corrosive effects including tis-
sue death (necrosis) in humans [Schmidt and 
Maibach 1981; Horch et al. 1994], rats [Con-
ning and Hayes 1970], mice [Patrick et al. 1985], 
and pigs [Pullin et al. 1978; Hunter et al.1992]. 
Other effects, such as erythema, inflammation, 
discoloration, eczema, redness, and severe ede-
ma have been reported on contact of the skin 
with solid or liquid phenol [Brown et al. 1975; 
Conning and Hayes 1970]. The effects of phenol 
on the skin have been attributed to its ability to 
impair the barrier function of the stratum corne-
um and produce coagulation necrosis by dena-
turing and precipitating proteins. Although the 
structure-activity-relationship model,  DEREK™, 
predicts that phenol is nonirritating to the skin, 
which indicates that the chemical does not have 
structural alerts for skin irritation, several stud-
ies in humans and animals show that phenol is 
corrosive to the skin or is a skin irritant depend-
ing on the concentration.
Reports of necrosis and chemical burns in hu-
mans [Schmidt and Maibach 1981; Horch et al. 
1994] and animals [Conning and Hayes 1970; 
Pullin et al. 1978; Patrick et al. 1985; Hunter 
et al. 1992] following direct skin contact with 
undiluted phenol or concentrated solutions are 
sufficient to demonstrate the corrosivity of phe-
nol. More diluted solutions are more likely to be 
irritating to the skin. Therefore, this assessment 
assigns an SK: DIR (COR) notation for phenol. 
 • Application of Appendix A.2: Experi-
mental protocols for investigating di-
rect effects of skin exposure and derived 
criteria for assigning the SK: DIR nota-
tions. Sufficient evidence in the forms of 
numerous human and animal studies was 
identified that clearly demonstrated phe-
nol’s ability to cause direct effects includ-
ing inflammation, discoloration, eczema, 
redness, edema, and necrosis of the skin 
and underlying tissues. Based upon this 
evidence, phenol has been assigned both 
the DIR and (COR) subnotations.
F.4 Sensitization
Few studies have been identified that evaluated 
the potential of phenol to cause skin sensitiza-
tion in both humans and animals. In one study 
using 24 volunteers, phenol produced nega-
tive results in skin sensitization tests [Kligman 
1966]. The Magnussen and Kligman skin sen-
sitization test in guinea pigs also gave nega-
tive results for phenol [Itoh 1982]. Predictions 
using structure-activity-relationship models 
provide some information regarding this end-
point. Based on the chemical structure, phenol 
is predicted by DEREK™ as negative for sensi-
tization, indicating that the chemical does not 
have structural alerts for skin sensitization. 
This prediction of negative sensitization poten-
tial is consistent with the absence of published 
reports of sensitization in workers handling 
phenol and the limited empirical evidence. 
The limited information available indicates 
that phenol is not likely to be a skin sensitizer. 
Therefore, this assessment does not assign a 
SK: SEN notation for phenol.
 • Application of Appendix A.3: Experi-
mental protocols for investigating 
sensitization from skin exposure and 
derived criteria for assigning the SK: 
SEN Notations and Appendix C.2: Us-
ing structural alerts implemented in 
the DEREK™ expert system to identify 
sensitizers. This section reviews the as-
sembled data set for phenol to assess the 
potential for sensitization following skin 
exposures. The identified data set pro-
vided insufficient information to assign 
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the SEN notation. This decision is sup-
ported by the  inclusion of the DEREK™ 
negative prediction for phenol to cause 
 sensitization.
F.5 Summary
There is sufficient information from toxicoki-
netics [Feldman and Maibach 1970; Piotrowski 
1971; Baranowska-Dutkiewicz 1981], acute der-
mal toxicity studies [Conning and Hayes 1970; 
Brown et al. 1975; Vernot et al. 1977], and repeat-
dose dermal toxicity studies [Deichmann et al. 
1950; Boutwell and Bosch 1959] to indicate that 
phenol is absorbed through the skin and is acute-
ly toxic and induces systemic effects (e.g., central 
nervous system effects, effects on body weight 
and survival) following skin exposure. Infor-
mation from human experience [Merliss 1972; 
Schmidt and Maibach 1981; Horch et al. 1994] 
and animal studies [Conning et al. 1970; Pullin 
et al. 1978; Patrick et al. 1985; Hunter et al. 1992] 
is sufficient to demonstrate that phenol is corro-
sive and that more dilute solutions are irritating 
to the skin. The limited information available in-
dicates that phenol is not a skin sensitizer. There-
fore, this assessment recommends the composite 
skin notation of SK: SYS-DIR (COR) for phenol. 
Phenol has also been classified as being harmful 
and toxic upon contact with the skin and corro-
sive by the European Commission (EC) [2007]. 
ACGIH [2001], NIOSH [2006], and OSHA 
[2007] have also assigned a skin notation to the 
chemical. The classifications assigned by these 
organizations are indicated in Table F.2. Based 
on the scheme developed by NIOSH [2009] to 
coordinate the skin notations with the GHS, the 
equivalent GHS classification for phenol would 
most likely be Dermal Category 3 acute toxicant 
(200 mg/kg body weight < LD50 < 1000 mg/kg 
body weight) and Category 1 Skin Corrosive. 
Table F.2. Summary of skin hazard designations beyond NIOSH
Organization Skin hazard designations
NIOSH‡ [2006] Skin notation—potential for skin and eye irritation and dermal absorption
OSHA§ [2007] Skin notation—indicates that the cutaneous route of exposure (including mucous 
membranes and eyes) contributes to overall exposure
ACGIH† [2001] Skin notation—phenol, as a vapor, liquid, or solid, can penetrate the intact skin 
causing systemic effects
EC* [2007] R21—Harmful: danger of serious damage to health by prolonged contact with skin
R24—Toxic in contact with skin
R34—Corrosive: causes burns
C—Corrosive
‡NIOSH = National Institute for Occupational Safety and Health
§OSHA = Occupational Safety and Health Administration.
†ACGIH = American Conference of Governmental Industrial Hygienists
*EC = European Commission, Joint Research Center, Institute for Health and Consumer Protection
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G.1 Contaminants and isomers
Skin notations are intended to provide warn-
ings and salient facts about the adverse health 
effects associated with skin exposures to a 
neat chemical or mixture. Commercial-grade 
chemicals may contain a contaminant, which 
has been defined as the following:
1. A chemical that is unintentionally pres-
ent within a neat substance or mixture 
having a concentration less than 1.0% or
2. A chemical that is recognized as a poten-
tial carcinogen present within a neat sub-
stance or mixture having a concentration 
less than 0.1% [29 CFR 1910.1200 (2005)]
Contaminants may be discussed within the 
supporting documentation for a specific com-
pound, but the skin notations apply solely to 
the neat substance or mixture because of the 
potential for the contaminant to represent a 
unique occupational hazard. If a contaminant 
is deemed to represent a substantial health 
hazard for workers following contact of the 
skin, it may be independently evaluated to de-
termine whether assignment of skin notations 
is appropriate.
Isomers are molecules that exhibit unique 
physical structures, despite having the same el-
ementary composition and weight. Variations 
within the chemical properties of isomers of a 
molecule may result in substantial differences 
in toxic potency. Unless otherwise noted, skin 
notations derived for a chemical that displays 
isomerism apply strictly to the structural ar-
rangements specified within the supporting 
documentation of the compound. 
G.2 Globally Harmonized 
System of Classification 
and Labeling of Chemicals
GHS is an international classification and la-
beling system for chemicals adopted by the 
U.N. in 2003 to ensure their safe use, transport, 
and disposal [UNECE 2005]. The GHS crite-
ria for the classification of chemicals is based 
on health (toxicological), physical (flammabil-
ity), and environmental hazards and specify-
ing what information should be included on 
labels of hazardous chemicals and material 
safety data sheets. The GHS criteria outlines 
a similar strategy as presented in this CIB for 
the classification and labeling of chemicals to 
warn against the health risks of skin exposures, 
including systemic toxicity, skin irritation or 
corrosivity, and sensitization [UNECE 2005]. 
The strategy outlined in this CIB has been pur-
posely designed to correspond with GHS to 
encourage harmonization between the two sys-
tems. Table G.2 has been included to illustrate 
the harmonization of the GHS classification 
system and the new NIOSH skin notations for 
acute systemic toxicity (lethality), direct effects 
of the skin, and sensitization. The GHS assign-
ment will be included within the skin notation 
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profiles to support the assignment of the new 
NIOSH skin notations.
It should be noted that in some cases the 
NIOSH skin notation assignments and hazard 
statements found on labels and material safety 
data sheets prepared in accordance with the 
GHS may vary because of differences associ-
ated with (1) professional judgment and inter-
ruption of reviewed data and (2) deviations be-
tween the criteria outlined in the NIOSH and 
GHS strategies. The classification of hazards 
associated with skin exposures to chemicals 
under the NIOSH and GHS strategies relies 
heavily on the use of professional judgment 
during the evaluation of the scientific data and 
subsequent assignment of the hazard designa-
tions. For this reason, differences in the in-
terruption of the reviewed data may result in 
discrepancies for a particular substance. An 
additional reason that potential differences 
may occur is because of variations in the cri-
teria outlined in this CIB and the GHS, such 
as the numeric cutoff values applied to assess 
critical effects in animal studies. Although the 
strategy outlined in this CIB has been designed 
to harmonize with GHS, differences between 
the NIOSH skin notation assignment and haz-
ard statements developed using the GHS strat-
egy can be reasonably anticipated. 
Table G.2 Coordination of the GHS classification system and the  
new NIOSH skin notations
Health hazard
GHS assignment  
(mg/kg body weight)
NIOSH assignment
(mg/kg body weight)
Acute systemic toxicity 
(lethality)
Dermal Category 1: 
Symbol: Skull and Crossbones 
Signal word: Danger 
Hazard Statement: Fatal in contact with skin 
(Criteria: LD50 < 50)
        OR
Dermal Category 2: 
Symbol: Skull and Crossbones 
Signal word: Danger 
Hazard Statement: Fatal in contact with skin 
(Criteria: 50 < LD50 < 200)
SK: SYS (FATAL) 
(Criteria: LD50 < 200)
(Continued)
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Table G.2 (Continued). Coordination of the GHS classification system and the  
new NIOSH skin notations
Health hazard
GHS assignment  
(mg/kg body weight)
NIOSH assignment
(mg/kg body weight)
 Acute systemic toxicity 
(lethality) 
(Continued)
Dermal Category 3: 
Symbol: Skull and Crossbones 
Signal word: Danger 
Hazard Statement: Toxic in contact with skin 
(Criteria: 200 < LD50 < 1000)
        OR
Dermal Category 4: 
Symbol: Exclamation mark 
Signal word: Warning 
Hazard Statement: Harmful in contact with skin 
(Criteria: 1000 < LD50 < 2000)
SK: SYS 
(Criteria: 200 < LD50 < 
2000)
  Dermal Category 5: 
Symbol: No symbol 
Signal word: Warning 
Hazard Statement: May be harmful in contact 
with skin  
(Criteria: 2000 < LD50 < 5000)
No equivalent assignment
Direct effects of the skin Skin Corrosion Category 1:
Symbol: Corrosion
Signal word: Danger
Hazard Statement: Causes severe skin burns 
and eye damage
SK: DIR (COR)
  Skin Irritation Category 2: 
Symbol: Exclamation mark 
Signal word: Warning 
Hazard Statement: Causes skin irritation
SK: DIR (IRR)
  Skin Irritation Category 3: 
Symbol: No symbol 
Signal word: Warning 
Hazard Statement: May be harmful in contact 
with skin
SK: DIR
Skin Sensitization Skin Sensitization Category 1: 
Symbol: Exclamation mark 
Signal word: Warning 
Hazard Statement: May cause an allergic skin 
reaction
SK: SEN
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G.3 Cancer
Cancer refers to any one of a group of diseases 
that occurs when cells in the body become ab-
normal and grow or multiply out of control. 
Exposure of the skin to some chemicals has 
been demonstrated to contribute to the de-
velopment of (1) cancers within internal or-
gan systems beyond the point of contact and 
(2) cancers of the skin at or near the point of 
contact. To ensure consistency in the assign-
ment of the skin notations, the following para-
digm has been developed:
 • Cancers occurring within an internal 
organ system or tissue beyond the point 
of contact are defined as systemic effects 
and warrant the assignment of the SYS 
notation.
 • Cancers occurring at or near the point of 
contact on the skin are defined as direct 
effects and warrant the assignment of the 
DIR notation.
The weight-of-evidence approach described 
within this CIB will be applied to assess the 
potential for a chemical to act as a carcinogen 
following exposures of the skin and the sub-
sequent assignment of the SYS and DIR nota-
tions when appropriate. In addition, the Skin 
Notation Profiles (see Appendix F) will sum-
marize the data associated with carcinogenic 
potential of a chemical, including cancer des-
ignations provided by NIOSH, NTP, U.S. EPA, 
IARC, and ACGIH. 
G.4 Nanoparticles and the skin 
Nanotechnology is a system of innovative meth-
ods to control and manipulate matter at near-
atomic scale (1–100 nanometers) to produce new 
materials, structures, and devices. Examples of 
nanoparticles include carbon-based materials 
(i.e., nanotubes and fullerenes),  metal-based 
materials (i.e., quantum dots, metal oxides, 
nanogold, and nanosilver), nanocomposites, 
and dendrimers. Because of their small size and 
relatively large surface area, engineered nanopar-
ticles may have chemical, physical, and biologic 
properties distinctly different from and greater 
than fine particles of similar chemical composi-
tion [NIOSH 2009]. These variations may result 
in unique health hazards for workers employed 
to manufacture or use products containing 
 nanomaterials.
Limited information is currently available to ac-
curately assess the health hazards of skin expo-
sures to nanoparticles. The results from in vitro 
studies using primary or cultured human skin 
cells show that single-walled and multi-walled 
carbon nanotubes are able to enter cells and 
cause the release of proinflammatory cytokines, 
oxidative stress, and decreased viability [Shve-
dova et al. 2003; Monteiro-Riviere et al. 2005]. 
More recent studies have reported the ability of 
quantum dots and fullerenes to penetrate the 
stratum corneum by passive diffusion and to 
induce inflammatory response and cytotoxicity 
within skin fibroblasts and keratinocytes [Sayes 
et al. 2005; Ryman-Rasmussen et al. 2006]. Fac-
tors including size, shape, water solubility, and 
surface coating may directly affect a nanopar-
ticle’s potential to penetrate the skin [Sayes et al. 
2004; Ryman-Rasmussen et al. 2006].
The occupational health hazards of exposing 
skin to the different forms of nanoparticles are 
unclear. For this reason, skin notations derived 
from neat substances or mixtures with simi-
lar chemical composition to a specific form of 
nanoparticles may not be applicable because 
of the different physicochemical properties 
and toxic potential. As new data become avail-
able, the skin notations and supporting docu-
mentation will address the toxic potential of 
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nanoparticles when warranted. Additional in-
formation and guidance on safe work practices 
associated with nanoparticles can be found 
within the NIOSH document, Approaches to 
Safe Nanotechnology: Managing the Health and 
Safety Concerns with Engineered Nanomateri-
als [NIOSH 2009]. 
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